Background {#Sec1}
==========

During a 24-h day, each given period is spent in either sedentary behaviour, sleeping, light-intensity physical activity (LPA), or moderate-to-vigorous physical activity (MVPA) \[[@CR1], [@CR2]\]. It has been well documented that all of these time-use components across a 24 h spectrum may be significantly associated with health. For instance, an increased risk of all-cause mortality, cardiovascular disease, metabolic syndrome, type 2 diabetes mellitus (T2D), and certain types of cancer is associated with low levels of MVPA, large amounts of time spent in sedentary behaviour and inappropriate sleep duration \[[@CR1]--[@CR10]\]. As the duration of a day is fixed and finite, a change in one of these movement-related behaviours will result in a net equal and opposite change in other behaviours. Despite this fact, most previous epidemiological studies have analysed the associations of each behaviour in isolation; that is, without taking into account the displacement of the remaining co-dependent behaviours.

In recent years, there has been growing interest in exploring how all the behaviours across the energy expenditure spectrum influence health outcomes \[[@CR1], [@CR2], [@CR11]--[@CR15]\]. In the seminal work by Mekary et al. \[[@CR12]\], the isotemporal substitution model (ISM) was proposed as a method for evaluating the displacement of one movement-related behaviour time-use component with another, while allowing adjustment for the confounding effect of the remaining time-use components \[[@CR12]\]. In addition to the ISM proposed by Mekary et al. \[[@CR12]\], Chastin et al. \[[@CR13]\] and Dumuid et al. \[[@CR14]\] recently introduced two different compositional isotemporal substitution models that account for the compositional properties of time-use data \[[@CR1], [@CR2], [@CR15]\]. The findings of studies employing ISM may improve our understanding of the interrelationships between different movement-related behaviours and their relationships to health and may also help in shaping public health guidelines and promotion strategies \[[@CR11]\]. Whilst, for example, most public health guidelines on physical activity recommend people to engage in a certain amount of MVPA, they lack an instruction on which movement/non-movement behaviour should preferably be displaced by MVPA \[[@CR16], [@CR17]\]. Studies using ISM may enable creating specific, evidence-based recommendations on favourable reallocations of time between sleep, sedentary behaviour, and physical activity, which has the potential to improve the translation of research findings on these behaviours into practice, and, consequently, increase the uptake of public health messages.

A recent meta-analysis of five studies using ISM concluded that reallocating sedentary time to MVPA was significantly associated with a reduction in percentage of body fat \[[@CR18]\]. However, the review focused only on studies conducted among children, with markers of adiposity being the only outcome of interest. An increasing number of ISM-based studies conducted in all age groups have recently been published, investigating outcomes such as adiposity, metabolic biomarkers, mental health, chronic musculoskeletal pain, fitness, mortality, and health-related quality of life \[[@CR19]--[@CR39]\].

A comprehensive review on the topic of time reallocation and its associations on health outcomes seems warranted, to summarise the current state of knowledge in this growing field and provide directions for its future development. Therefore, the aim of this paper was threefold: (i) to review and summarise findings from studies that employed ISM in sleep, sedentary behaviour, and physical activity research; (ii) appraise the methodological quality of the studies; and (iii) suggest future research directions.

Methods {#Sec2}
=======

Protocol {#Sec3}
--------

The methods employed in this review were registered in advance in the PROSPERO register of systematic reviews (ref: CRD42017071606). The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed in this systematic scoping review \[[@CR40]\].

Search strategy {#Sec4}
---------------

A systematic search of the following databases was performed in July 2017: Academic Search Premier, CINAHL, Health Source: Nursing/Academic Edition, MasterFILE Premier, PsycINFO, PubMed/MEDLINE, Scopus, SPORTDiscus, and Web of Science (including Arts & Humanities Citation Index, Conference Proceedings Citation Index- Science, Conference Proceedings Citation Index- Social Science & Humanities, Science Citation Index Expanded, and Social Sciences Citation Index). The following keywords were used for the search: "physical activity", "physical inactivity", sedentar\*, sleep\*, sitting, standing, isotemporal, compositional. The terms used for the search were combined with Boolean operators (Additional file [1](#MOESM1){ref-type="media"}). No limitations regarding publication date were applied. The search results were downloaded and scrutinized in the EndNote software X8 (Clarivate Analytics, New York, USA). A secondary search was performed by: (i) screening the reference lists of each read full-text; and (ii) by performing forward citation tracking of the included studies through Google Scholar and Scopus.

Inclusion criteria {#Sec5}
------------------

To be included in the current review, studies were required to meet the following criteria: (i) the study was published in an English-language refereed journal with full-text availability; (ii) the study was an original research (reviews were not considered) with data collected among human participants; (iii) the study used ISM to explore the association between reallocating relevant movement-related behaviours (e.g., sleep, sedentary behaviour, LPA and/or MVPA) and health outcomes. The World Health Organisation \[[@CR41]\] defines health as the absence of disease and frailty, as well as complete physical, mental, and social well-being. For the purpose of this paper, any analysed outcome aligned with this definition was considered a health outcome. Observational studies conducted in any age group were considered.

Study coding and data extraction {#Sec6}
--------------------------------

The information extracted from the included studies comprised descriptive data including: the geographic location of the study; study design; sample size; measures of sleep, sedentary behaviour, LPA, and MVPA; the ISM used; amount of reallocated time; adjustments for confounding; and the main findings related to the health outcome(s). The data were extracted and tabulated to an Excel spreadsheet predefined for the purpose of this review.

Methodological quality appraisal {#Sec7}
--------------------------------

In order to assess the methodological quality of the studies that met the inclusion criteria we used the Newcastle--Ottawa quality assessment scale for observational studies \[[@CR42]\]. The scale details can be found elsewhere \[[@CR42]\]. The maximum score on the scale was eight. Studies that scored more than six points were considered of high quality, studies scoring 4--6 points were considered as moderate quality and studies with scores less than four points were considered as being of low methodological quality \[[@CR43]\].

The search and methodological quality appraisal was performed independently by two authors of the review (JG and EGB). In addition, two authors (JG and NS) independently performed the data extraction. Any discrepancies between the reviewers were resolved with discussion and consensus or in consultation with a third investigator (ZP).

Results {#Sec8}
=======

Study selection {#Sec9}
---------------

In total, 5859 items were screened in the study selection process. The initial database search identified 1741 results. For 88 studies the full-text was retrieved and assessed for eligibility. Of those, 48 studies met the inclusion criteria. Forward citation tracking of the included studies yielded another 1789 search results, of which eight studies were included. By screening through the reference lists of all the included studies (2329 results) we identified no additional studies relevant for this review. Therefore, the total number of studies included in this review is 56 \[[@CR12], [@CR13], [@CR19]--[@CR39], [@CR44]--[@CR76]\]. The search and study selection process is depicted in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Flow diagram of the search process

Study characteristics {#Sec10}
---------------------

Of the 56 included studies, 36 had a cross-sectional design while 18 were prospective cohort studies. Two studies reported both cross-sectional and prospective relationships. Most of the studies were performed in the USA (*n* = 21), eleven studies were performed in the UK, five in Australia, four in Sweden, three in the Netherlands, two in Canada and Spain, and one in Portugal, Norway, Japan, Greenland, Finland, China, and Denmark. One study used data from Brazil, Europe, and the USA. Accelerometers were used in 41 studies, self-reports were used in 12 studies, while heart rate and other movement monitors were used in three studies. Most studies did not include all the relevant daily or 24-h movement-related behaviours. For example, sleep duration was included in only 22 studies. Associations were reported for exchanged time varying from one minute to 120 min/day across the studies, with 30 min/day being the most common reallocation. The model proposed by Mekary et al. \[[@CR12]\] was used in 53 studies. Two studies used the model proposed by Chastin et al. \[[@CR13]\], and one study used the model proposed by Dumuid et al. \[[@CR14]\].

Participants and outcomes {#Sec11}
-------------------------

The sample sizes of the included studies ranged from 87 to 423,659 participants. The median number of participants per study was 1497. Studies were performed in children and youth \[[@CR20], [@CR21], [@CR23], [@CR25], [@CR27], [@CR28], [@CR45], [@CR49], [@CR59], [@CR60], [@CR63], [@CR64], [@CR70]\], adults \[[@CR12], [@CR13], [@CR22], [@CR24], [@CR30]--[@CR33], [@CR35], [@CR36], [@CR38], [@CR39], [@CR46], [@CR48], [@CR50]--[@CR52], [@CR54]--[@CR56], [@CR58], [@CR62], [@CR65]--[@CR69], [@CR71], [@CR72], [@CR75], [@CR76]\], older adults \[[@CR26], [@CR29], [@CR45], [@CR48], [@CR61]\] and clinical populations \[[@CR19], [@CR34], [@CR53], [@CR57], [@CR73], [@CR74]\]. The outcomes were categorised into six major categories: mortality (*n* = 9 studies; Table [1](#Tab1){ref-type="table"}), perceived health (*n* = 6 studies; Table [2](#Tab2){ref-type="table"}), mental health (*n* = 3 studies; Table [3](#Tab3){ref-type="table"}), adiposity (*n* = 29 studies; Table [4](#Tab4){ref-type="table"}), fitness (*n* = 8 studies; Table [5](#Tab5){ref-type="table"}), cardiometabolic biomarkers (*n* = 18 studies; Table [6](#Tab6){ref-type="table"}) and chronic diseases and conditions (*n* = 6 studies; Table [7](#Tab7){ref-type="table"}). Some of the studies assessed multiple outcomes, therefore, the total number of exceeds 56.Table 1Summary of the findings from the studies assessing mortality outcomesStudySample and study designMeasures of sleep, SB, LPA, MVPAOutcome measuresData analysis method/reallocated timeAdjustments for confoundingResultsChomistek et al. \[[@CR50]\]Men (*n* = 44,551) from The Health Professionals Follow-up Study, USA; prospective cohortLPA, MPA, VPA -- self report; sleep, SB -- not assessedSum of total CVD risk factors, total cancer, or other nontraumatic death.Mekary et al. \[[@CR12]\]/10 MET h-wk^− 1^Smoking, aspirin use, vitamin E supplement use, parental history of myocardial infarction or cancer, alcohol consumption, energy-adjusted intake of polyunsaturated fat, trans fatty acids, omega-3 fatty acids, fiber, diabetes, hypertension, and hypercholesterolemia.HR (95% CI)\
MPA → VPA: 0.96 (0.93, 0.99)Fishman et al. \[[@CR54]\]Adults (*n* = 3029) from the 2003--2004 and 2005--2006 waves of the National Health and Nutrition Examination Survey, USA; prospective cohortSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedMortality riskMekary et al. \[[@CR12]\]/10, 30 and 60 minAge, sex, race/ethnicity, education, and minutes of device wear time (model 1). Model 2 includes BMI, smoking, the presence of diabetes, coronary heart disease, congestive heart failure, stroke, cancer, and mobility limitation. In model 3 those with prevalent chronic illnesses (diabetes, coronary heart disease, congestive heart failure, stroke, and cancer) or mobility limitations at baseline were excluded.HR (95% CI)\
10 min reallocation\
Model 1\
SB → LPA: 0.90 (0.88, 0.93)\
SB → MVPA: 0.73 (0.57, 0.94)\
MVPA → LPA: 1.23 (0.96, 1.58)\
MVPA → SB: 1.36 (1.06, 1.75)\
Model 2\
SB → LPA: 0.92 (0.89, 0.94)\
SB → MVPA: 0.79 (0.63, 0.99)\
MVPA → LPA: 1.15 (0.92, 1.44)\
MVPA → SB: 1.26 (1.01, 1.58)\
Model 3\
SB → LPA: 0.91 (0.86, 0.96)\
SB → MVPA: 0.70 (0.57, 0.85)\
MVPA → LPA: 1.30 (1.06, 1.59)\
MVPA → SB: 1.43 (1.17, 1.74)\
Reallocating 30 or 60 min from SB to LPA or MVPA was associated with a reduction in mortality risk after 5 years of follow-up.Lee \[[@CR62]\]Adults (*n* = 7006) from the National Health and Nutrition Examination Survey, USA; prospective cohortSB, LPA, MPA, VPA -- waist-worn accelerometers; sleep -- not assessedAll-cause mortalityMekary et al. \[[@CR12]\]/1 min and a dose-response analysisAge, sex, education level, income, BMI, binge drinking, smoking status, energy intake by 24-h dietary recall, self-reported general health condition, high blood pressure, high cholesterol, type 2 diabetes, history of heart attack, stroke, and cancer.Reallocating 1 min of SB to LPA or MPA demonstrated a J-shaped association with mortality, with the turning point at about\
400 min and 15 min per day, respectively.\
Reallocating time from SB to VPA decreased all-cause mortality in a linear manner.Loprinzi et al. \[[@CR65]\]Adults (*n* = 5377) from the 2003--2006 National Health and Nutrition Examination Survey, USA; prospective cohortSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedMortalityMekary et al. \[[@CR12]\]/30 minAge, sex, race--ethnicity, BMI, smoking status and educationHR (95% CI)\
SB → LPA: 0.87 (0.80, 0.95)\
SB → MVPA: 0.19 (0.06, 0.60)\
LPA → SB: 1.14 (1.04, 1.24)\
LPA → MVPA: 0.22 (0.07, 0.69)\
MVPA → SB: 5.03 (1.64, 15.40)\
MVPA → LPA: 4.40 (1.42, 13.56)Matthews et al. \[[@CR66]\]Less active (*n* = 69,606) and more active (*n* = 85,008) individuals from the NIH-AARP Diet and Health Study, USA; prospective cohortSleep, SB, exercise and non-exercise activities, LPA, MVPA -- self reportAll-cause and cardiovascular mortalityMekary et al. \[[@CR12]\]/60 minAge, education, smoking history, sleep duration, overall health, BMI, overall sitting, each type of physical activity, and the sum of overall sitting and physical activity timeHR (95% CI)\
All-cause mortality\
Less active individuals\
SB → exercise: 0.58 (0.54, 0.63)\
SB → non-exercise: 0.70 (0.66, 0.74)\
SB → household chores: 0.80 (0.74, 0.86)\
SB → lawn and garden: 0.49 (0.43, 0.56)\
SB → daily walking: 0.66 (0.57, 0.78)\
SB → LPA: 0.81 (0.75, 0.88)\
SB → MVPA: 0.58 (0.54, 0.62)\
More active individuals\
SB → exercise: 0.91 (0.88, 0.94)\
SB → non-exercise: 1.00 (0.98, 1.02)\
SB → household chores: 1.02 (0.99, 1.05)\
SB → lawn and garden: 0.97 (0.93, 1.01)\
SB → daily walking: 0.99 (0.94, 1.05)\
SB → LPA: 1.04 (1.01, 1.08)\
SB → MVPA: 0.96 (0.94, 0.98)\
The time reallocations for cardiovascular mortality were weaker and non-significant among less active men for household chores, daily walking, and LPA compared to women. An increase in the risk was noted when reallocating SB with household and LPA in more active men. A significant inverse association for replacing SB with lawn and garden activities in more active men was noted (the same was not observed among women).Matthews et al. \[[@CR67]\]Adults (*n* = 4840) from the 2003--2006 National Health and Nutrition Examination Survey, USA; prospective cohortSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedMortality riskMekary et al. \[[@CR12]\]/60 minAge, sex, race-ethnicity, alcohol consumption, smoking status, BMI, self-reported diabetes, coronary artery disease, stroke, cancer, and mobility limitation.HR (95% CI)\
Overall\
SB → LPA: 0.82 (0.73, 0.92)\
SB → MVPA: 0.58 (0.44, 0.77)\
Less active individuals\
SB → LPA: 0.80 (0.69, 0.92)\
SB → MVPA: 0.37 (0.26, 0.54)\
More active individuals\
SB → LPA: 1.29 (0.95, 1.74)\
SB → MVPA: 0.92 (0.60, 1.43)Schmid et al. \[[@CR71]\]Adults (*n* = 3702) from the National Health and Nutrition Examination Survey 2003--2004 and 2005--2006 cycles, USA; prospective cohortSB, LPA, MVPA -- accelerometers (location is not presented); sleep -- not assessedAll-cause mortality, CVD mortality, cancer mortalityMekary et al. \[[@CR12]\]/30 minAge, sex, total accelerometer wear time (model 1). Model 2 is additionally adjusted for education, ethnicity, height, smoking, alcohol consumption, total dietary fat intake, total dietary fibre intake, mobility\
limitations, history of diabetes, history of coronary heart disease, history of congestive heart failure, history of stroke, history of cancer. Model 3 is the same as model 2 plus waist circumference.HR (95% CI)\
All-Cause Mortality\
Model 1\
SB → LPA: 0.85 (0.81, 0.88)\
SB → MVPA: 0.38 (0.22, 0.63)\
SB → LPA and MVPA: 0.82 (0.79, 0.85)\
LPA → MVPA: 0.45 (0.26, 0.75)\
Model 2\
SB → LPA: 0.86 (0.83, 0.90)\
SB → MVPA: 0.50 (0.31, 0.80)\
SB → LPA and MVPA: 0.85 (0.81, 0.88)\
LPA → MVPA: 0.58 (0.36, 0.93)\
Model 3\
SB → LPA: 0.88 (0.84, 0.92)\
SB → MVPA: 0.51 (0.32, 0.83)\
SB → LPA and MVPA: 0.86 (0.82, 0.90)\
LPA → MVPA: 0.58 (0.36, 0.95)\
CVD Mortality\
Model 1\
SB → LPA: 0.84 (0.77, 0.90)\
SB → MVPA: 0.25 (0.09, 0.71)\
SB → LPA and MVPA: 0.80 (0.74, 0.86)\
LPA → MVPA: 0.30 (0.11, 0.86)\
Model 2\
SB → LPA: 0.86 (0.79, 0.93)\
SB → MVPA: 0.35 (0.14, 0.92)\
SB → LPA and MVPA: 0.83 (0.77, 0.90)\
LPA → MVPA: 0.41 (0.16, 1.08)\
Model 3\
SB → LPA: 0.88 (0.81, 0.95)\
SB → MVPA: 0.36 (0.13, 0.95)\
SB → LPA and MVPA: 0.85 (0.78, 0.92)\
LPA → MVPA: 0.41 (0.15, 1.11)\
Cancer mortality\
Model 1\
SB → LPA: 0.91 (0.85, 0.98)\
SB → MVPA: 0.53 (0.22, 1.31)\
SB → LPA and MVPA: 0.88 (0.82, 0.96)\
LPA → MVPA: 0.58 (0.24, 1.44)\
Model 2\
SB → LPA: 0.92 (0.85, 0.99)\
SB → MVPA: 0.69 (0.32, 1.50)\
SB → LPA and MVPA: 0.90 (0.83, 0.98)\
LPA → MVPA: 0.75 (0.34, 1.63)\
Model 3\
SB → LPA: 0.93 (0.86, 1.01)\
SB → MVPA: 0.79 (0.39, 1.62)\
SB → LPA and MVPA: 0.92 (0.85, 1.00)\
LPA → MVPA: 0.85 (0.41, 1.73)Stamatakis et al. \[[@CR72]\]Adults (*n* = 201,129) from the 45 and Up study from New South Wales, Australia; prospective cohortSleep, SB, LPA, MVPA -- self reportAll-cause mortalityMekary et al. \[[@CR12]\]/60 minAge, sex, educational level, marital status, residence, BMI, smoking status, self-rated health, receiving help with daily tasks for a long-term illness or disability, prevalent disease at baseline, psychological distress, mutually adjusted for all activity classes, and total time in all activity classes.HR (95% CI)\
Sleeping (≤7 h) → screen-time: 1.01 (0.98, 1.05)\
Sleeping (≤7 h) → sitting: 1.03 (0.99, 1.07)\
Sleeping (≤7 h) → standing: 0.98 (0.94, 1.02)\
Sleeping (≤7 h) → walking: 0.93 (0.84, 1.03)\
Sleeping (≤7 h) → MVPA: 0.90 (0.85, 0.96)\
Sleeping (≤7 h) → total activity: 1.01 (0.98, 1.04)\
Sleeping (\> 7 h) → screen-time: 0.95 (0.93, 0.97)\
Sleeping (\> 7 h) → sitting: 0.96 (0.94, 0.98)\
Sleeping (\> 7 h) → standing: 0.92 (0.9, 0.94)\
Sleeping (\> 7 h) → walking: 0.80 (0.75, 0.86)\
Sleeping (\> 7 h) → MVPA: 0.84 (0.81, 0.87)\
Sleeping (\> 7 h) → total activity: 1.06 (1.04, 1.07)\
Screen-time → sleeping (≤7 h): 0.95 (0.91, 0.99)\
Screen-time → sleeping (\> 7 h): 1.06 (1.04, 1.09)\
Screen-time → sitting: 1.01 (1.00, 1.03)\
Screen-time → standing: 0.97 (0.95, 0.98)\
Screen-time → walking: 0.87 (0.82, 0.92)\
Screen-time → MVPA: 0.89 (0.86, 0.91)\
Screen-time → total activity: 1.01 (1.00, 1.02)\
Sitting → sleeping (≤7 h): 0.94 (0.90, 0.98)\
Sitting → sleeping (\> 7 h): 1.05 (1.03, 1.07)\
Sitting → screen-time: 0.99 (0.97, 1.00)\
Sitting → standing: 0.95 (0.94, 0.96)\
Sitting → walking: 0.86 (0.81, 0.90)\
Sitting → MVPA: 0.88 (0.85, 0.90)\
Sitting → total activity: 1.02 (1.01, 1.03)\
Standing → sleeping (≤7 h): 0.99 (0.95, 1.03)\
Standing → sleeping (\> 7 h): 1.10 (1.08, 1.13)\
Standing → screen-time: 1.04 (1.02, 1.05)\
Standing → sitting: 1.05 (1.04, 1.06)\
Standing → walking: 0.90 (0.85, 0.95)\
Standing → MVPA: 0.92 (0.89, 0.95)\
Standing → total activity: 0.98 (0.97, 0.99)\
Walking → sleeping (≤7 h): 1.10 (1.03, 1.18)\
Walking → sleeping (\> 7 h): 1.17 (1.12, 1.21)\
Walking → screen-time: 1.15 (1.09, 1.22)\
Walking → sitting: 1.17 (1.11, 1.23)\
Walking → standing: 1.11 (1.05, 1.18)\
Walking → MVPA: 1.02 (0.96, 1.09)\
Walking → total activity: 0.88 (0.83, 0.93)\
MVPA → sleeping (≤7 h): 1.07 (1.02, 1.13)\
MVPA → sleeping (\> 7 h): 1.18 (1.14, 1.22)\
MVPA → screen-time: 1.13 (1.09, 1.16)\
MVPA → sitting: 1.14 (1.11, 1.18)\
MVPA → standing: 1.09 (1.06, 1.12)\
MVPA → walking: 0.98 (0.92, 1.04)\
MVPA → total activity: 0.90 (0.87, 0.92)Wijndaele et al. \[[@CR39]\]Middle-aged adults (*n* = 423,659) from the UK Biobank cohort study, UK; prospective cohortSB (leisure screen time, TV viewing, computer usage) and leisure/home activities (walking for pleasure, light and heavy do-it-yourself), structured exercise, sleep -- self reportedMortality riskMekary et al. \[[@CR12]\]/30 minTownsend deprivation index, alcohol intake, smoking status, salt adding behaviour, oily fish consumption, fruit and vegetable intake, processed and sleep duration, chronic disease status, parental history of cardiovascular disease or diabetesHR (95% CI)\
Screen time → leisure/home activities: 0.95 (0.94, 0.97)\
Screen time → structured exercise: 0.87 (0.84, 0.90)\
Screen time → walking for pleasure: 0.95 (0.92, 0.98)\
Screen time → light do-it-yourself: 0.97 (0.94, 1.00)\
Screen time → heavy do-it-yourself: 0.93 (0.90, 0.96)\
Screen time → strenuous sports: 0.87 (0.79, 0.95)\
Screen time → other exercises: 0.88 (084, 0.91)\
TV viewing → leisure/home activities: 0.94 (0.93, 0.96)\
TV viewing → structured exercise: 0.87 (0.84, 0.90)\
TV viewing → walking for pleasure: 0.94 (0.92, 0.97)\
TV viewing → light do-it-yourself: 0.96 (0.94, 0.99)\
TV viewing → heavy do-it-yourself: 0.91 (0.89, 0.95)\
TV viewing → strenuous sports: 0.86 (0.79, 0.95)\
TV viewing → other exercises: 0.87 (0.83, 0.91)\
Men\
Computer usage → leisure/home activities: 0.98 (0.96, 1.00)\
Computer usage → structured exercise: 0.89 (0.85, 0.93)\
Computer usage → walking for pleasure: 0.98 (0.95, 1.01)\
Computer usage → light do-it-yourself: 0.99 (0.96, 1.02)\
Computer usage → heavy do-it-yourself: 0.97 (0.93, 1.00)\
Computer usage → strenuous sports: 0.90 (0.81, 0.99)\
Computer usage → other exercises: 0.88 (0.84, 0.93)\
Women\
Computer usage → leisure/home activities: 0.94 (0.91, 0.97)\
Computer usage → structured exercise: 0.90 (0.84, 0.96)\
Computer usage → walking for pleasure: 0.93 (0.89, 0.98)\
Computer usage → light do-it-yourself: 0.99 (0.94, 1.04)\
Computer usage → heavy do-it-yourself: 0.84 (0.76, 0.94)\
Computer usage → strenuous sports: 0.88 (0.73, 1.06)\
Computer usage → other exercises: 0.90 (0.84, 0.97)*SB* sedentary behaviour, *LPA* light intensity physical activity, *MVPA* moderate-to-vigorous intensity physical activity, *MPA* moderate intensity physical activity, *VPA* vigorous intensity physical activity, *CVD* cardiovascular disease, *BMI* body mass index, *MET* metabolic equivalent of task, *HR* hazard ratio, *CI* confidence intervalTable 2Summary of the findings from the studies assessing perceived/general health statusStudySample and study designMeasures of sleep, SB, LPA, MVPAOutcome measuresData analysis method/reallocated timeAdjustments for confoundingResultsBalboa-Castillo et al. \[[@CR45]\]Older adults (*n* = 1097), Spain; prospective cohortSleep, SB, housework, leisure-time physical activity (LPA, MVPA) -- self-reportHRQoLMekary et al. \[[@CR12]\]/60 minAge, sex, educational level, size of municipality of residence, consumption of tobacco, consumption of alcohol, self-reported diseases diagnosed by a physician, score on appropriate SF-36 scale in 2003, number of hours lying or sleeping, and total number of hours spent in all types of physical activity.β (95% CI)\
Physical functioning\
SB ↔ LPA: 3.41 (0.81, 6.00)\
SB ↔ MVPA: 4.14 (1.92, 6.37)\
SB ↔ housework: 1.04 (0.25, 1.85)\
Physical role\
SB ↔ LPA: 10.61 (6.08, 15.13)\
SB ↔ MVPA: 1.19 (− 2.71, 5.10)\
SB ↔ housework: 1.68 (0.27, 3.01)\
Bodily pain\
SB ↔ LPA: 4.22 (1.19, 7.26)\
SB ↔ MVPA: 2.93 (0.31, 5.56)\
SB ↔ housework: 1.05 (0.10, 1.99)\
General health\
SB ↔ LPA: 2.44 (0.66, 4.23)\
SB ↔ MVPA: − 0.06 (− 1.61, 1.50)\
SB ↔ housework: 0.31 (− 0.24, 0.87)\
Vitality\
SB ↔ LPA: 4.14 (1.58, 6.71)\
SB ↔ MVPA: 2.51 (0.29, 4.73)\
SB ↔ housework: 0.67 (− 0.13, 1.47)\
Social functioning\
SB ↔ LPA: 4.80 (1.84, 7.77)\
SB ↔ MVPA: 2.06 (− 0.47, 4.61)\
SB ↔ housework: 1.08 (0.14, 2.00)\
Emotional role\
SB ↔ LPA: 4.93 (0.98, 8.87)\
SB ↔ MVPA: 1.03 (− 2.40, 4.46)\
SB ↔ housework: 1.21 (− 0.03, 2.45)\
Mental health\
SB ↔ LPA: 2.51 (0.17, 4.86)\
SB ↔ MVPA: 0.53 (− 1.51, 2.57)\
SB ↔ housework: 0.83 (0.09, 1.57)Buman et al. \[[@CR47]\]Older adults (*n* = 862) from the 2005--2007 Senior Neighborhood Quality of Life Study, USA; prospective cohortSB, MVPA ("high-light" physical activity and "low-light" physical activity) -- waist-worn accelerometers; sleep -- not assessedPhysical health and psychosocial well-being factorsMekary et al. \[[@CR12]\]/30 minAge, sex, race, educational status, marital status, senior housing status, current smoking status and walkability index.β (95% CI)\
Physical health\
SB → "low-light" physical activity: 0.07 (0.04, 0.09)\
SB → "high-light" physical activity: 0.30 (0.19, 0.42)\
SB → MVPA: 0.34 (0.23, 0.44)\
"Low-light" physical activity → SB: − 0.07 (− 0.09, − 0.04)\
"Low-light" physical activity → "high-light" physical activity: 0.24 (0.11, 0.36)\
"Low-light" physical activity → MVPA: 0.21 (0.10, 0.32)\
"High-light" physical activity → SB: − 0.30 (− 0.42, − 0.19)\
"High-light" physical activity → "low-light" physical activity: − 0.24 (− 0.36, − 0.11)\
"High-light" physical activity → MVPA: − 0.27 (− 0.55, 0.01)\
MVPA → SB: − 0.17 (− 0.22, − 0.12)\
MVPA → "low-light" physical activity: − 0.10 (− 0.16, − 0.05)\
MVPA → "high-light" physical activity: 0.14 (− 0.06, 0.27)\
Psychosocial well-being\
SB → "low-light" physical activity: 0.01 (− 0.02, 0.04)\
SB → "high-light" physical activity: 0.24 (0.12, 0.36)\
SB → MVPA: − 0.02 (− 0.13, 0.10)\
"Low-light" physical activity → SB: − 0.01 (− 0.04, 0.02)\
"Low-light" physical activity → "high-light" physical activity: 0.24 (0.10, 0.37)\
"Low-light" physical activity → MVPA: − 0.03 (− 0.15, 0.08)\
"High-light" physical activity → SB: − 0.24 (− 0.36, − 0.12)\
"High-light" physical activity → "low-light" physical activity: − 0.24 (− 0.37, − 0.10)\
"High-light" physical activity → MVPA: − 0.50 (− 0.81, − 0.19)\
MVPA → SB: 0.01 (− 0.05, 0.07)\
MVPA → "low-light" physical activity: 0.02 (− 0.04, 0.08)\
MVPA → "high-light" physical activity: 0.25 (0.10, 0.41)Fanning et al. \[[@CR26]\]Low-active healthy older adults (*n* = 247), USA; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- self reportSelf-regulation, spatial working memory, task-switchingMekary et al. \[[@CR12]\]/30 minAge, sex, race.β (standard error)\
Self-regulation -- total score\
SB → LPA: 0.60 (0.38)\
SB → MVPA: 1.81 (0.80)\
SB → sleep: 1.29 (0.39)\
Self-regulation -- self-monitoring\
SB → LPA: 0.15 (0.09)\
SB → MVPA: 0.27 (0.19)\
SB → sleep: 0.23 (0.09)\
Self-regulation -- goal setting\
SB → LPA: 0.11 (0.08)\
SB → MVPA: 0.27 (0.18)\
SB → sleep: 0.32 (0.09)\
Self-regulation -- social support\
SB → LPA: 0.09 (0.06)\
SB → MVPA: 0.08 (0.13)\
SB → sleep: 0.18 (0.07)\
Spatial working memory -- item 2 reaction time\
SB → LPA: − 0.16 (6.20)\
SB → MVPA: − 4.46 (13.09)\
SB → sleep: 1.13 (6.50)\
Spatial working memory -- item 3 reaction time\
SB → LPA: − 0.19 (6.18)\
SB → MVPA: − 5.60 (13.06)\
SB → sleep: − 1.11 (6.49)\
Spatial working memory -- item 4 reaction time\
SB → LPA: − 5.87 (6.57)\
SB → MVPA: − 4.61 (13.88)\
SB → sleep: − 0.21 (6.89)\
Spatial working memory -- item 2 accuracy\
SB → LPA: − 0.01 (0.00)\
SB → MVPA: 0.03 (0.01)\
SB → sleep: − 0.00 (0.01)\
Spatial working memory -- item 3 accuracy\
SB → LPA: − 0.01 (0.01)\
SB → MVPA: 0.02 (0.01)\
SB → sleep: − 0.00 (0.01)\
Spatial working memory -- item 4 accuracy\
SB → LPA: − 0.00 (0.01)\
SB → MVPA: 0.01 (0.01)\
SB → sleep: − 0.00 (0.01)\
Task-switching -- single reaction time\
SB → LPA: 7.45 (5.01)\
SB → MVPA: − 23.12 (10.63)\
SB → sleep: 4.12 (5.31)\
Task-switching -- mixed-repeat reaction time\
SB → LPA: 5.00 (6.24)\
SB → MVPA: − 27.06 (13.24)\
SB → sleep: − 12.2 (6.61)\
Task-switching -- mixed-switch reaction time\
SB → LPA: 1.04 (8.23)\
SB → MVPA: − 28.24 (17.45)\
SB → sleep: − 17.21 (8.71)\
Task-switching -- local switch cost reaction time\
SB → LPA: − 3.93 (5.98)\
SB → MVPA: − 0.40 (12.67)\
SB → sleep: − 5.19 (6.33)\
Task-switching -- global switch cost reaction time\
SB → LPA: − 2.84 (6.39)\
SB → MVPA: − 1.54 (13.55)\
SB → sleep: − 16.86 (6.77)\
Task-switching -- single accuracy\
SB → LPA: − 0.00 (0.00)\
SB → MVPA: 0.01 (0.01)\
SB → sleep: − 0.01 (0.00)\
Task-switching -- mixed-repeat accuracy\
SB → LPA: − 0.01 (0.01)\
SB → MVPA: 0.01 (0.01)\
SB → sleep: − 0.01 (0.01)\
Task-switching -- mixed-switch accuracy\
SB → LPA: − 0.01 (0.01)\
SB → MVPA: 0.01 (0.01)\
SB → sleep: − 0.01 (0.01)\
Task-switching -- local switch accuracy\
SB → LPA: 0.00 (0.00)\
SB → MVPA: 0.00 (0.01)\
SB → sleep: − 0.00 (0.00)\
Task-switching -- global switch accuracy\
SB → LPA: 0.00 (0.01)\
SB → MVPA: − 0.00 (0.01)\
SB → sleep: 0.01 (0.01)Loprinzi et al. \[[@CR65]\]Adults (*n* = 5377) from the 2003--2006 National Health and Nutrition Examination Survey, USA; prospective cohortSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedHRQoLMekary et al. \[[@CR12]\]/30 minAge, sex, race--ethnicity, BMI, smoking status and educationβ (95% CI)\
HRQoL\
SB → LPA: 0.92 (0.85, 1.01)\
SB → MVPA: 0.28 (0.13, 0.58)\
LPA → SB: 1.07 (0.98, 1.17)\
LPA → MVPA: 0.30 (0.14, 0.65)\
MVPA→ SB: 3.54 (1.70, 7.40)\
MVPA → LPA: 3.3 (1.54, 7.02)Vallance et al. \[[@CR34]\]Non-Hodgkin lymphoma survivors (*n* = 149) from the Western Australian\
Cancer Registry, Australia; cross-sectionalSB bouts and non-bouts, standing, LPA, MVPA bouts and non-bouts -- waist-worn accelerometers; sleep -- self reportFatigue and HRQoLMekary et al. \[[@CR12]\]/30 minSex, non-Hodgkin lymphoma type and time since diagnosis, country of birth, highest level of education, working status, comorbidity and non-Hodgkin lymphoma treatmentβ (95% CI)\
Fatigue\
Sleep ↔ SB bouts: 0.1 (− 1.0, 1.1)\
Sleep ↔ SB non-bouts: 0.6 (− 0.5, 1.8)\
Sleep ↔ LPA: 0.3 (− 0.8, 1.4)\
Sleep ↔ MVPA non-bouts: 1.2 (− 2.4, 4.8)\
Sleep ↔ MVPA bouts: 5.7 (1.8, 9.7)\
SB bouts ↔ SB non-bouts: 0.5 (− 0.3, 1.4)\
SB bouts ↔ LPA: 0.2 (− 0.5, 0.9)\
SB bouts ↔ MVPA non-bouts: 1.1 (− 2.3, 4.5)\
SB bouts ↔ MVPA bouts: 5.7 (1.6, 9.7)\
SB non-bouts ↔ LPA: − 0.3 (− 1.5, 0.8)\
SB non-bouts ↔ MVPA non-bouts: 0.6 (− 2.6, 3.9)\
SB non-bouts ↔ MVPA bouts: 5.1 (1.0, 9.3)\
LPA ↔ MVPA non-bouts: 0.9 (− 2.9, 4.8)\
LPA ↔ MVPA bouts: 5.5 (1.5, 9.5)\
MVPA non-bouts ↔ MVPA bouts: 4.5 (− 1.4, 10.5)\
HRQoL\
Sleep ↔ SB bouts: − 0.6 (− 1.9, 0.8)\
Sleep ↔ SB non-bouts: − 0.2 (− 1.7, 1.3)\
Sleep ↔ LPA: − 0.6 (− 2.1, 0.9)\
Sleep ↔ MVPA non-bouts: 0.0 (− 4.7, 4.8)\
Sleep ↔ MVPA bouts: 4.5 (− 0.8, 9.7)\
SB bouts ↔ SB non-bouts: 0.4 (− 0.8, 1.5)\
SB bouts ↔ LPA: − 0.1 (− 0.9, 0.8)\
SB bouts ↔ MVPA non-bouts: 0.6 (− 3.9, 5.1)\
SB bouts ↔ MVPA bouts: 5.0 (− 0.4, 10.4)\
SB non-bouts ↔ LPA: − 0.4 (− 1.9, 1.1)\
SB non-bouts ↔ MVPA non-bouts: 0.2 (− 4.1, 4.5)\
SB non-bouts ↔ MVPA bouts: 4.6 (− 0.8, 10.1)\
LPA ↔ MVPA non-bouts: 0.6 (− 4.4, 5.7)\
LPA ↔ MVPA bouts: 5.1 (− 0.2, 10.4)\
MVPA non-bouts ↔ MVPA bouts: 4.4 (− 3.5, 12.3)Van Roekel et al. \[[@CR73]\]Colorectal cancer survivors (*n* = 145) from the Energy for life after ColoRectal cancer study, Netherlands; cross-sectionalSleep, SB, standing, physical activity (defined as \> 1.5 METs) -- triaxial MOX activity monitorHRQoLMekary et al. \[[@CR12]\]/60 minAge, sex, number of comorbidities, smoking status, time since diagnosis, cancer stage, BMI, perceived deficiency in social support score, chemotherapy received, stoma, tumor subsite, education level and having a partner.β (95% CI)\
Global quality of life\
SB → standing: 1.0 (0.7, 1.5)\
SB → physical activity: 1.2 (0.6, 2.5)\
Standing → physical activity: 1.2 (0.5, 3.1)\
Physical functioning\
SB → standing: 1.1 (0.7, 1.7)\
SB → physical activity: 1.7 (0.8, 3.7)\
Standing → physical activity: 1.5 (0.5, 4.3)\
Role functioning\
SB → standing: 1.2 (0.8, 1.8)\
SB → physical activity: 0.7 (0.3, 1.5)\
Standing → physical activity: 0.6 (0.2, 1.6)\
Social functioning\
SB → standing: 1.2 (0.8, 1.8)\
SB → physical activity: 0.6 (0.3, 1.3)\
Standing → physical activity: 0.5 (0.2, 1.4)\
Disability\
SB → standing: 0.6 (0.4, 0.9)\
SB → physical activity: 0.9 (0.4, 1.9)\
Standing → physical activity: 1.6 (0.6, 4.2)\
Fatigue\
SB → standing: 1.0 (0.6, 1.4)\
SB → physical activity: 0.6 (0.3, 1.3)\
Standing → physical activity: 0.7 (0.3, 1.7)\
Depression\
SB → standing: 1.1 (0.7, 1.6)\
SB → physical activity: 0.8 (0.4, 1.6)\
Standing → physical activity: 0.8 (0.3, 1.9)\
Anxiety\
SB → standing: 1.1 (0.7, 1.5)\
SB → physical activity: 0.7 (0.4, 1.5)\
Standing → physical activity: 0.7 (0.3, 1.7)*SB* sedentary behaviour, *LPA* light intensity physical activity, *MVPA* moderate-to-vigorous intensity physical activity, *MPA* moderate intensity physical activity, *HRQoL* health-related quality of life, *MET* metabolic equivalent of task, *CI* confidence intervalTable 3Summary of the findings from the studies assessing mental health outcomesStudySample and study designMeasures of sleep, SB, LPA, MVPAOutcome measuresData analysis method/reallocated timeAdjustments for confoundingResultsJanssen \[[@CR60]\]Children (*n* = 20,122) from the Canadian Health Behavior in School-aged Children study, Canada; cross-sectionalSedentary video games, active outdoor play, active video games -- self report; sleep -- not assessedMental health outcomesMekary et al. \[[@CR12]\]/60 minSex, school grade, household structure, race, immigration status, socioeconomic status, smoking, frequency of drunkenness, active travel to school, participation in sport, and a diet composition factor score.PR (95% CI)\
High emotional problems\
Sedentary video games → active outdoor play: 0.94 (0.91, 0.97)\
Active outdoor play → active video games: 1.07 (1.03, 1.11)\
Active video games → sedentary video games: 1.07 (1.03, 1.10)\
Active video games → active outdoor play: 0.93 (0.90, 0.97)\
Sedentary video games → active outdoor play: 0.88 (0.85, 0.90)\
Active outdoor play → sedentary video games: 1.14 (1.11, 1.17)\
High life satisfaction\
Sedentary video games → active outdoor play: 1.04 (1.02, 1.07)\
Active outdoor play → active video games: 0.97 (0.95, 0.99)\
Active video games → sedentary video games: 0.96 (0.94, 0.98)\
Active video games → active outdoor play: 1.04 (1.01, 1.06)\
Sedentary video games → active outdoor play: 1.08 (1.06, 1.10)\
Active outdoor play → sedentary video games: 0.92 (0.91, 0.94)\
High prosocial behaviour\
Sedentary video games → active outdoor play: 1.13 (1.09, 1.16)\
Active outdoor play → active video games: 0.94(0.91, 0.98)\
Active video games → sedentary video games: 0.89 (0.86, 0.92)\
Active video games → active outdoor play: 1.06 (1.02, 1.10)\
Sedentary video games → active outdoor play: 1.19 (1.16, 1.22)\
Active outdoor play → sedentary video games: 0.84 (0.82, 0.86)Mekary et al. \[[@CR69]\]Adult women (*n* = 32,900) from the Nurses' Health Study, USA; prospective cohortTelevision watching, easy walking pace, average walking pace, brisk/very brisk walking pace, jogging/running, other physical activities, total discretionary time -- self report; sleep -- not assessedRisk of depressionMekary et al. \[[@CR12]\]/60 minAge, weight, smoking, menopausal status, use of postmenopausal hormone therapy, previously diagnosed medical conditions, marital status, osteoarthritis, social or community group involvement, wealth and income, education, occupation, working status and educational level.RR (95% CI)\
TV watching → easy walking: 1.32 (0.73, 2.38)\
TV watching → average walking: 0.88 (0.77, 1.00)\
TV watching → brisk walking: 0.76 (0.68, 0.85)\
TV watching → running: 0.76 (0.45, 1.29)\
TV watching → other activities: 0.93 (0.85, 1.01)\
TV watching → total discretionary time: 1.03 (1.02, 1.05)\
Easy walking → TV watching: 0.73 (0.42, 1.26)\
Easy walking → average walking: 0.65 (0.37, 1.12)\
Easy walking → brisk walking: 0.56 (0.32, 0.96)\
Easy walking → running: 0.56 (0.26, 1.19)\
Easy walking → other activities: 0.68 (0.39, 1.18)\
Easy walking → total discretionary time: 1.42 (0.82, 2.45)\
Average walking → TV watching: 1.13 (0.99, 1.29)\
Average walking → easy walking: 1.49 (0.82, 2.71)\
Average walking → brisk walking: 0.86 (0.74, 0.99)\
Average walking → running: 0.86 (0.50, 1.48)\
Average walking → other activities: 1.05 (0.89, 1.24)\
Average walking → total discretionary time: 0.91 (0.80, 1.04)\
Brisk walking → TV watching: 1.32 (1.18, 1.47)\
Brisk walking → easy walking: 1.73 (0.96, 3.13)\
Brisk walking → average walking: 1.16 (1.00, 1.34)\
Brisk walking → running: 1.00 (0.58, 1.72)\
Brisk walking → other activities: 1.22 (1.05, 1.42)\
Brisk walking → total activity: 0.79 (0.70, 0.88)\
Running → TV watching: 1.19 (0.74, 1.91)\
Running → easy walking: 1.56 (0.74, 3.32)\
Running → average walking: 1.05 (0.64, 1.70)\
Running → brisk walking: 0.90 (0.55, 1.46)\
Running → other activities: 1.10 (0.68, 1.80)\
Running → total discretionary time: 0.87 (0.54, 1.40)\
Other activities → TV Watching: 1.08 (0.99, 1.17)\
Other activities → easy walking: 1.42 (0.78, 2.56)\
Other activities → average walking: 0.95 (0.80, 1.11)\
Other activities → brisk walking: 0.81 (0.70, 0.95)\
Other activities → running: 0.82 (0.48, 1.40)\
Other activities → total discretionary time: 0.96 (0.88, 1.05)Rethorst et al. \[[@CR31]\]Adults (*n* = 11,116) from the Hispanic Community Health Study/Study of Latinos, USA; cross-sectionalSB, LPA, MPA, VPA -- waist-worn accelerometers; sleep -- not assessedDepressive symptomsMekary et al. \[[@CR12]\]/60 minAge, sex, Hispanic background group, BMI, household income level, and education level, recruitment site, physical health and acculturation.β (95% CI)\
SB ↔ LPA: − 0.003 (− 0.113, 0.107)\
SB ↔ MPA: 0.285 (− 0.264, 0.834)\
SB ↔ VPA: − 1.215 (− 2.250, − 0.180)\
LPA ↔ MPA: 0.288 (− 0.304, 0.880)\
LPA ↔ VPA: − 1.212 (− 2.244, − 0.179)\
MPA ↔ VPA: − 1.5 (− 2.883, − 0.116)*SB* sedentary behaviour, *LPA* light intensity physical activity, *MVPA* moderate-to-vigorous intensity physical activity, *MPA* moderate intensity physical activity, *VPA* vigorous physical activity, *BMI* body mass index, *PR* prevalence ratio, *RR* relative risk, *CI* confidence intervalTable 4Summary of the findings from the studies assessing adiposityStudySampleMeasures of sleep, SB, LPA, MVPAOutcome measuresData analysis method / reallocated timeAdjustments for confoundingResultsAggio et al. \[[@CR44]\]Children and youth (*n* = 353) from the Camden Active Spaces project, UK; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedBody fatMekary et al. \[[@CR12]\] / 60 minAge, sex, ethnicity, height and school deprivation.β (95% CI)\
Body fat\
SB ↔ LPA: − 0.774 (− 1.714, 0.167)\
SB ↔ MVPA: 4.187 (1.142, 7.233)\
LPA ↔ MVPA: − 4.961 (− 8.212, − 1.710)Boyle et al. \[[@CR19]\]Adult breast cancer survivors (*n* = 256) from the ACCEL-Breast study, Australia; cross-sectionalSB (prolonged SB and non-prolonged SB), LPA, MVPA -- waist-worn accelerometers; sleep -- self reportWaist circumference, BMIMekary et al. \[[@CR12]\] / 30 minAge, socioeconomic status, comorbidity, and smoking statusβ (95% CI)\
Waist circumference\
Sleep ↔ prolonged SB: 0.00 (− 0.85, 0.85)\
Sleep ↔ non-prolonged SB: − 0.94 (− 1.80, − 0.08)\
Sleep ↔ LPA: 0.20 (− 0.68, 1.09)\
Sleep ↔ MVPA: − 2.50 (− 4.45, − 0.56)\
Prolonged SB ↔ non-prolonged SB: − 0.94 (− 1.79, − 0.10)\
Prolonged SB ↔ LPA: 0.20 (− 0.34, 0.74)\
Prolonged SB ↔ MVPA: − 2.51 (− 4.38, − 0.64)\
Non-prolonged SB ↔ LPA: 1.14 (0.18, 2.10)\
Non-prolonged SB ↔ MVPA: − 1.56 (− 3.40, 0.27)\
LPA ↔ MVPA: − 2.71 (− 4.72, − 0.69)\
BMI\
Sleep ↔ prolonged SB: 0.17 (− 0.20, 0.55)\
Sleep ↔ non-prolonged SB: − 0.23 (− 0.62, 0.15)\
Sleep ↔ LPA: 0.10 (− 0.30, 0.49)\
Sleep ↔ MVPA: − 0.75 (− 1.61, 0.11)\
Prolonged SB ↔ non-prolonged SB: − 0.41 (− 0.79, − 0.03)\
Prolonged SB ↔ LPA: − 0.08 (− 0.32, 0.16)\
Prolonged SB ↔ MVPA: − 0.93 (− 1.75, − 0.10)\
Non-prolonged SB ↔ LPA: 0.33 (− 0.10, 0.77)\
Non-prolonged SB ↔ MVPA: − 0.52 (− 1.34, 0.30)\
LPA ↔ MVPA: − 0.85 (− 1.75, 0.05)Buman et al. \[[@CR48]\]Adults (*n* = 2185 -- full sample; *n* = 923 -- fasting sub-sample) from the 2005--2006 US National Health and Nutrition Examination Survey, USA; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- self reportWaist circumferenceMekary et al. \[[@CR12]\] / 30 minSex, race, marital status, education, work status, income, smoking, depressive symptoms, 24-h dietary recalls estimating intakes of total energy, saturated fat, caffeine, and alcohol, a general health rating, diagnosis of cancer, malignancy, CVD, or diabetes, and current use of diabetic, antihypertensive, lipidemic, or other CVD medication.RR (95% CI)\
Waist circumference\
Sleep → MVPA: 0.976 (0.966, 0.985)\
SB → MVPA: 0.973 (0.965, 0.981)\
LPA → MVPA: 0.974 (0.966, 0.983)\
Sleep → LPA: 1.001 (0.998, 1.005)\
SB → LPA: 0.999 (0.996, 1.001)\
SB → sleep: 0.997 (0.993, 1.001)Carson et al. \[[@CR49]\]Children and youth aged 6--17 years (*n* = 4169 -- full sample; *n* = 1242 -- fasting sub-sample) from the Canadian Health Measures Survey, Canada; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- self reportBMI, waist circumference, blood pressure, behavioural strengths and difficulties, CRF -- full sample. Triglycerides, HDL, C-reactive protein, and insulin -- fasting subsample.Chastin et al. \[[@CR13]\] / 10 minAge, sex, and highest household education.Reallocating 10 min of MVPA to SB, LPA or sleep, resulted in a 5.1, 1.2, and 1.1% increase in BMI z score, respectively.\
Reallocating 10 min of SB, LPA or sleep, to MVPA resulted in a less than 1% decrease in BMI z score.\
Similar effects were noted across all health indicators.Chastin et al. \[[@CR13]\]Adults (*n* = 1937) from the National Health and Nutrition Examination Survey 2005--2006 cycle, USA; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- self reportBMIChastin et al. \[[@CR13]\] / 10 minAge, sex, ethnicity/race, self-reported health, diagnosis of health conditions, educational level, social economic status, smoking status, alcohol consumption, calorie intake, caffeine and fat, medications for diabetes and/or high blood pressure.Reallocating 10 min of MVPA to SB resulted in a 1.2% change in BMI.Collings et al. \[[@CR20]\]Children (*n* = 410) from the Physical Activity and Nutrition in Children study, Finland; cross-sectionalSleep, SB, LPA, MPA, VPA -- heart rate and movement sensorBMI, body composition (FMI, TFMI, FFMI),Mekary et al. \[[@CR12]\] / 10 minAge, sex, monitor wear characteristics, income, sleep duration, energy intake, frequency of breakfast consumption, number of meals per day, snacking, birth weight, maternal and paternal BMI. When FMI, TFMI and FFMI were outcomes further adjustment for CRF was made. CRF was adjusted for FMI.β (95% CI)\
FMI\
SB → LPA: − 1.2 (− 1.8, − 0.64)\
SB → MPA: − 1.7 (− 2.7, − 0.78)\
SB → VPA: − 11.8 (− 17.4, − 5.8)\
LPA → MPA: − 0.51 (− 1.7, 0.73)\
LPA → VPA: − 10.7 (− 16.2, − 4.8)\
MPA → VPA: − 10.2 (− 16.4, − 3.5)\
TFMI\
SB → LPA: − 1.5 (− 2.1, − 0.82)\
SB → MPA: − 2.0 (− 3.2, − 0.83)\
SB → VPA: − 13.1 (− 20.1, − 5.5)\
LPA → MPA: − 0.58 (− 2.0, 0.86)\
LPA → VPA: − 11.8 (− 18.8, − 4.3)\
MPA → VPA: − 11.3 (− 19.0, − 2.9)\
FFMI\
SB → LPA: − 0.0026 (− 0.013, 0.0079)\
SB → MPA: 0.016 (− 0.0002, 0.031)\
SB → VPA: − 0.042 (− 0.12, 0.033)\
LPA → MPA: 0.018 (− 0.0042, 0.041)\
LPA → VPA: -0.039 (− 0.11, 0.034)\
MPA → VPA: − 0.057 (− 0.14, 0.024)Collings et al. \[[@CR21]\]Children (*n* = 333) from the Born in Bradford birth cohort study, UK; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- self report or estimated from accelerometersBMI, waist circumference, sum of skinfoldsMekary et al. \[[@CR12]\] / 20 minAge, sex, ethnicity, index of multiple deprivation, monitor wear time, season of assessment and height.β (95% CI)\
BMI\
SB → LPA: − 0.0096 (− 0.055, 0.036)\
SB → MVPA: 0.052 (− 0.039, 0.14)\
LPA → MVPA: 0.061 (− 0.054, 0.18)\
Waist circumference\
SB → LPA: − 0.034 (− 0.21, 0.15)\
SB → MVPA: − 0.11 (− 0.46, 0.24)\
LPA → MVPA: − 0.077 (− 0.53, 0.37)\
Sum of skinfolds\
SB → LPA: 0.048 (− 0.37, 0.47)\
SB → MVPA: − 0.77 (− 1.46, − 0.084)\
LPA → MVPA: − 0.82 (− 1.71, 0.062)Dahl-Petersen et al. \[[@CR22]\]Adults (*n* = 1497) from the Inuit Health in Transition study (2005--2010), Greenland; cross-sectionalSB, LPA, MPA, VPA --combined accelerometer and heart rate monitor; sleep -- not assessedBMI, waist circumference, visceral fat and subcutaneous abdominal adipose tissueMekary et al. \[[@CR12]\] / 60 minAge, sex, smoking and fraction of weekend wear time (model 1) and BMI (model 2).β (95% CI)\
Model 1\
BMI\
SB → LPA: − 0.21 (− 0.37, − 0.04)\
SB → MPA: − 0.47 (− 0.81, − 0.14)\
LPA → MPA: − 0.27 (− 0.67, 0.14)\
LPA → VPA: − 1.68 (− 2.89, − 0.46)\
Waist circumference\
SB → LPA: 0.57 (− 1.00, − 1.13)\
SB → MPA: − 1.13 (− 2.01, − 0.26)\
LPA → MPA: − 0.56 (− 1.63, 0.50)\
LPA → VPA: − 6.05 (− 9.20, − 2.30)\
Visceral fat\
SB → LPA: − 0.04 (− 0.11, 0.04)\
SB → MPA: − 0.23 (− 0.39, − 0.08)\
LPA → MPA: − 20 (− 0.38, − 0.02)\
LPA → VPA: − 0.66 (− 1.21, − 0.11)\
Sub-cutaneous fat\
SB → LPA: − 0.08 (− 0.12, − 0.03)\
SB → MPA: − 0.05 (− 0,15, 0.04)\
LPA → MPA: 0.02 (− 0.09, 0.14)\
LPA → VPA: − 0.67 (− 1.01, − 0.34)\
Model 2\
Waist circumference\
SB → LPA: − 0.007 (− 0.16, 0.14)\
SB → MPA: − 0.01 (− 0.32, 0.30)\
LPA → MPA: − 0.002(− 0.37, 0.37)\
LPA → VPA: − 1.9(− 3.0, − 0.80)\
Visceral fat\
SB → LPA: 0.03 (− 0.02, 0.09)\
SB → MPA: − 0.10 (− 0.21, 0.02)\
LPA → MPA: − 0.13 (− 0.27, 0.007)\
LPA → VPA: − 0.17 (− 0.58,0.25)\
Sub-cutaneous fat\
SB → LPA: − 0.03 (− 0.06, 0.005)\
SB → MPA: 0.04 (− 0.02, 0.10)\
LPA → MPA: 0.07 (− 0.01, 0.15)\
LPA → VPA: − 0.33 (− 0.56, − 0.10)Dalene et al. \[[@CR23]\]Samples of 6-year-olds (girls, *n* = 495--512; boys, *n* = 475--494) 9 (girls, *n* = 1198--1219; boys, *n* = 1225-1253) and 15-year-olds (girls, *n* = 778--850; boys, *n* = 766--824) from the Physical Activity among Norwegian Children Study, Norway; cross-sectionalSB, LPA, MPA, VPA -- waist-worn accelerometers; sleep -- not assessedBMI, waist circumferenceMekary et al. \[[@CR12]\] / 10 minAge at baseline, sex, follow-up time, BMI and waist circumference at baseline.β (95% CI)\
Cross-sectional analyses\
BMI\
6-year-old girls\
SB → LPA: 0.10 (0.04, 0.17)\
SB → MPA: − 0.18 (− 0.35, − 0.01)\
SB → VPA: − 0.21 (− 0.58, 0.16)\
6-year-old boys\
SB → LPA: 0.08 (0.02, 0.15)\
SB → MPA: 0.03 (− 0.05, 0.12)\
SB → VPA: − 0.32 (− 0.71, 0.06)\
9-year-olds\
SB → LPA: − 0.32 (− 0.71, 0.06)\
SB → MPA: − 0.08 (− 0.15, − 0.02)\
SB → VPA: − 0.83 (1.04, − 0.63)\
15-year-olds\
SB → LPA: 0.03 (− 0.02, 0.07)\
SB → MPA: 0.06 (− 0.02, 0.15)\
SB → VPA: − 0.56 (− 0.87, − 0.25)\
Prospective analyses\
SB → LPA: 0.05 (− 0.00, 0.11)\
SB → MPA: − 0.05 (− 0.14, 0.04)\
SB → VPA: 0.16 (− 0.17, 0.49)\
Waist circumference\
6-year-old girls\
SB → LPA: 0.29 (0.13, 0.45)\
SB → MPA: − 0.47 (− 0.85, − 0.10)\
SB → VPA: − 0.15 (− 1.20, 0.90)\
6-year-old boys\
SB → LPA: 0.15 (− 0.02, 0.33)\
SB → MPA: 0.06 (− 0.16, 0.29)\
SB → VPA: − 0.79 (− 1.68, 0.10)\
9-year-olds\
SB → LPA: 0.17 (0.10, 0.25)\
SB → MPA: − 0.32 (− 0.46, − 0.18)\
SB → VPA: − 1.79 (− 2.36, − 1.23)\
15-year-olds\
SB → LPA: 0.17 (0.06, 0.28)\
SB → MPA: 0.02 (− 0.20, 0.24)\
SB → VPA: − 1.08 (− 1.94, − 0.21)\
Prospective analyses\
SB → LPA: 0.07 (− 0.08, 0.23)\
SB → MPA: − 0.09 (− 0.37, 0.20)\
SB → VPA: − 0.43 (− 1.29, 0.42)Ekblom-Bak et al. \[[@CR51]\]Adults (*n* = 836) from the Swedish Cardio Pulmonary bioImage Study, Sweden; cross-sectionalSB, LPA, MPA, VPA -- waist-worn accelerometers; sleep -- not assessedWaist circumferenceMekary et al. \[[@CR12]\] / 1, 5, 10, 15, 20, 25, 30, 60, 90 and 120 minAge, sex, education level, smoking habits, perceived psychological stress, energy intake and wear time.OR (95% CI)\
10-min reallocation\
High waist circumference\
SB → LPA: 0.97 (0.95, 0.98)\
SB → MPA: 0.94 (0.88, 0.99)\
SB → VPA: 0.62 (0.48, 0.79)Ekblom-Bak et al. \[[@CR52]\]Adults (*n* = 654) from the Swedish Cardio Pulmonary bioImage Study, Sweden; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedWaist circumferenceMekary et al. \[[@CR12]\] / 1, 5,\
10, 15, 20, 25, 30, 60, 90 and 120 minSex, age, education, smoking, perceived psychosocial stress.RR (95% CI)\
30 min reallocation\
Waist circumference (women \< 88 and men \< 102)\
SB → LPA: 0.982 (0.962, 1.003)\
SB → MVPA: 0.931 (0.878, 0.987)\
Waist circumference (women ≥88 and men ≥102)\
SB → LPA: 0.981 (0.954, 1.009)\
SB → MVPA: 0.880 (0.816, 0.950)Fairclough et al. \[[@CR25]\]Children (*n* = 169) from the Active Schools Skelmersdale study, UK; cross-sectionalSB, LPA, MVPA -- wrist-worn accelerometers; sleep -- estimated from the ActiGraph raw accelerationsBMI, waist circumferenceDumuid et al. \[[@CR14]\] / 15 minIMD decile, age, sex, and BMI.Reallocating 15 min from MVPA to sleep, SB or LPA predicted higher adiposity.\
Reallocating time to MVPA from sleep, SB or LPA increased the magnitude of estimated detriments for adiposity. Furthermore, the detriments were larger in magnitude than the estimated benefits of time reallocation from MVPA to sleep, SB or LPA.Falconer et al. \[[@CR53]\]Adults with type 2 diabetes (*n* = 519) from the Early Activity in Diabetes study, UK; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedBMI, waist circumferenceMekary et al. \[[@CR12]\] / 30 minAge, sex, ethnic group, IMD score, accelerometer wear time, relevant diabetes or lipid-lowering drugs.β (95% CI)\
BMI\
SB bouts → SB nonbouts: − 0.60 (− 1.0, − 0.21)\
SB bouts → LPA: − 0.26 (− 0.47, − 0.05)\
SB bouts →MVPA: − 2.19 (− 2.89, − 1.49)\
SB nonbouts →LPA: − 0.01 (− 0.38, 0.36)\
SB nonbouts →MVPA: − 1.87 (− 2.59, − 1.14)\
LPA → MVPA: − 2.00 (− 2.74, − 1.26)\
Waist circumference\
SB bouts → SB nonbouts: − 1.16 (− 2.08, − 0.25)\
SB bouts →LPA: − 0.87 (− 1.35, − 0.39)\
SB bouts →MVPA: − 4.56 (− 6.19, − 2.93)\
SB nonbouts →LPA: − 0.44 (− 1.30, 0.41)\
SB nonbouts →MVPA: − 3.97 (− 5.65, − 2.28)\
LPA →MVPA: − 3.93 (− 5.65, − 2.21)Gupta et al. \[[@CR55]\]Blue-Collar Workers (*n* = 692) from the PHysical ACTivity cohort, Denmark; cross-sectionalSB, standing time, MVPA -- thigh-worn accelerometers; sleep -- self reportBMI, waist circumference and body fat percentageMekary et al. \[[@CR12]\] / 30 minAge, sex, smoking status, alcohol intake, dietary patterns, and total measured time.β (95% CI)\
Whole day\
Waist circumference\
Total SB →standing: − 0.50 (− 0.81, − 0.18)\
Total SB →walking: 0.40 (− 0.53, 1.33)\
Total SB →MVPA: − 4.21 (− 6.94, − 1.47)\
Long SB bouts →standing: − 0.86 (− 1.22, − 0.5)\
Long SB bouts →walking: 0.57 (− 0.35, 1.5)\
Long SB bouts →MVPA: − 3.93 (− 6.62, − 1.23)\
Long SB bouts →moderate SB bouts: − 0.36 (− 0.89, 0.16)\
Long SB bouts →brief SB bouts: − 2.60 (− 3.55, − 1.65)\
Body fat percentage\
Total SB →standing: − 0.29 (− 0.45, − 0.13)\
Total SB →walking: 0.19 (− 0.26, 0.65)\
Total SB →MVPA: − 2.70 (− 4.03, − 1.37)\
Long SB bouts →standing: − 0.46 (− 0.65, − 0.27)\
Long SB bouts →walking: 0.27 (− 0.19, 0.72)\
Long SB bouts →MVPA: − 2.38 (− 3.7, − 1.06)\
Long SB bouts →moderate SB bouts: − 0.10 (− 0.38, 0.17)\
Long SB bouts →brief SB bouts: −1.43 (− 1.92, − 0.94)\
BMI\
Total SB →standing: − 0.17 (− 0.28, − 0.06)\
Total SB → walking:0.17 (− 0.15, 0.48)\
Total SB →MVPA: − 1.37 (− 2.29, − 0.44)\
Long SB bouts →standing: − 0.31 (− 0.44, − 0.17)\
Long SB bouts →walking: 0.18(− 0.14, 0.5)\
Long SB bouts →MVPA: − 1.28(− 2.2, − 0.35)\
Long SB bouts →moderate SBbouts: − 0.16 (− 0.35, 0.03)\
Long SB bouts →brief SB bouts: −0.82 (− 1.17, − 0.48)\
Work time\
Waist circumference\
Total SB →standing:− 0.24(− 0.6, 0.11)\
Total SB → walking:0.55 (− 0.38, 1.48)\
Total SB →MVPA: − 3.43 (− 6.25, − 0.61)\
Long SB bouts →standing: − 0.59 (− 1.16, − 0.03)\
Long SB bouts →walking: 0.67(− 0.36, 1.7)\
Long SB bouts →MVPA: − 3.42 (− 6.3, − 0.55)\
Long SB bouts →moderate SB bouts:− 0.08 (− 0.81, 0.66)\
Long SB bouts →brief SB bouts: −2.40 (− 3.43, − 1.36)\
Body fat percentage\
Total SB → standing:− 0.14 (− 0.32, 0.04)\
Total SB → walking:0.27 (− 0.19, 0.74)\
Total SB →MVPA: − 1.91 (− 3.29, − 0.52)\
Long SB bouts →standing: − 0.17(− 0.48, 0.13)\
Long SB bouts →walking: 0.47(− 0.06, 0.99)\
Long SB bouts →MVPA: − 1.50 (− 2.9, − 0.11)\
Long SB bouts →moderate SB bouts:0.20 (− 0.19, 0.6)\
Long SB bouts →brief SB bouts: −1.22 (− 1.76, − 0.68)\
BMI\
Total SB →standing: − 0.08(− 0.2, 0.05)\
Total SB → walking:0.25 (− 0.07, 0.57)\
Total SB →MVPA: − 1.03 (− 1.97, − 0.09)\
Long SB bouts →standing: − 0.17(− 0.38, 0.04)\
Long SB bouts →walking: 0.28 (− 0.08, 0.64)\
Long SB bouts →MVPA: − 0.96(− 1.92, 0.00)\
Long SB bouts →moderate SB bouts:− 0.02 (− 0.29, 0.26)\
Long SB bouts →brief SB bouts: −0.72 (− 1.1, − 0.35)\
Non-work time\
Waist circumference\
Total SB → standing:− 0.82 (− 1.26, − 0.37)\
Total SB → walking:− 0.02 (− 1.01, 0.97)\
Total SB → MVPA: −4.00 (− 6.75, − 1.26)\
Long SB bouts →standing: − 0.94 (− 1.39, − 0.49)\
Long SB bouts →walking: 0.33(− 0.62, 1.28)\
Long SB bouts →MVPA: − 3.77(− 6.51, − 1.03)\
Long SB bouts →moderate SB bouts: − 0.42 (− 0.97, 0.14)\
Long SB bouts → brief SB bouts: − 2.74 (− 3.77, − 1.72)\
Body fat percentage\
Total SB → standing: − 0.42 (− 0.65, − 0.19)\
Total SB → walking: 0.00 (− 0.49, 0.49)\
Total SB → MVPA: − 2.18 (− 3.53, − 0.84)\
Long SB bouts → standing: − 0.55 (− 0.78, − 0.32)\
Long SB bouts → walking: 0.09 (− 0.38, 0.55)\
Long SB bouts → MVPA: − 1.88 (− 3.22, − 0.55)\
Long SB bouts → moderate SB bouts: − 0.18 (− 0.46, 0.1)\
Long SB bouts → brief SB bouts: − 1.60 (− 2.11, − 1.09)\
BMI\
Total SB → standing: − 0.24 (− 0.4, − 0.08)\
Total SB → walking: 0.08 (− 0.25, 0.41)\
Total SB → MVPA: − 1.20 (− 2.12, − 0.28)\
Long SB bouts → standing: − 0.32 (− 0.48, − 0.16)\
Long SB bouts → walking: 0.13 (− 0.19, 0.45)\
Long SB bouts → MVPA: − 1.10 (− 2.02, − 0.18)\
Long SB bouts → moderate SB bouts: − 0.16 (− 0.36, 0.03)\
Long SB bouts → brief SB bouts: − 0.87 (− 1.22, − 0.52)Hamer et al. \[[@CR56]\]Adults (*n* = 445) from the Whitehall II epidemiological cohort, UK; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedBMIMekary et al. \[[@CR12]\] / 10 minAge, sex, smoking, employment grade, and current statin use.β (95% CI)\
BMI\
SB ↔ LPA: − 0.002 (− 0.059, 0.056)\
SB ↔ MVPA: − 0.39 (− 0.54, − 0.24)\
LPA ↔ MVPA: − 0.39 (− 0.55, − 0.22)Healy et al. \[[@CR58]\]A general population-based sample (*n* = 698) from the 2011/12 Australian Diabetes, Obesity, and Lifestyle Study, Australia; cross-sectionalSB, standing, stepping -- thigh-worn accelerometers; sleep -- self reportBMI, waist circumferenceMekary et al. \[[@CR12]\] / 120 minAge, sex, contraceptive pill use, blood pressure tablets, cholesterol tablets, diabetes medication, ethnicity, occupation and employment status, income, fibre intake, energy intake, energy-adjusted fibre intake, alcohol intake, sodium intake, potassium intake, fruit and vegetable serves.RR (95% CI)\
BMI\
Sitting → standing: 0.99 (0.97, 1.02)\
Sitting → stepping: 0.90 (0.86, 0.95)\
Standing → stepping: 0.91 (0.86, 0.96)\
β (95% CI)\
Waist circumference\
Sitting → standing: − 0.53 (− 3.08, 2.05)\
Sitting → stepping: − 7.48 (− 10.80, − 4.17)\
Standing → stepping: − 6.97 (− 11.05, − 2.89)Healy et al. \[[@CR57]\]Individuals with diagnosed type 2 diabetes (*n* = 279) from the Living Well with Diabetes intervention, Australia; cross-sectionalSB (prolonged SB and non-prolonged SB), LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedWaist circumference, BMIMekary et al. \[[@CR12]\] / 30 minAge, sex, BMI, waist circumference, log HbA1c, insulin use, oral hypoglycaemic use, use of glucagon-like-peptide-1 agents, diabetes duration, income, education, weight loss aids in last 6 months, smoking status, CVD-related condition, musculoskeletal condition, depression and/or anxiety, employment, place of birth, Caucasian, energy intake, diet quality score.β (95% CI)\
Waist circumference\
Prolonged SB → non-prolonged SB: − 0.69 (− 1.46, 0.08)\
Prolonged SB → LPA: − 0.77 (− 1.33, − 0.22)\
Prolonged SB → MVPA: 0.64 (− 1.96, 3.24)\
Non-prolonged SB → LPA: − 0.08 (− 0.93, 0.76)\
Non-prolonged SB → MVPA: 1.33 (− 1.31, 3.96)\
LPA → MVPA: 1.41 (− 1.37, 4.19)\
BMI\
Prolonged SB → non-prolonged SB: − 0.35 (− 0.70, − 0.01)\
Prolonged SB → LPA: − 0.36 (− 0.61, − 0.11)\
Prolonged SB → MVPA: 0.20 (− 0.93, 1.32)\
Non-prolonged SB → LPA: − 0.01 (− 0.38, 0.37)\
Non-prolonged SB → MVPA: 0.55 (− 0.58, 1.68)\
LPA → MVPA: 0.56 (− 0.64, 1.76)Huang et al. \[[@CR59]\]Children (*n* = 672) from the Understanding Children's Activity and Nutrition cohort study, China; prospective cohortSB (screen time, academic-related activities, other sedentary behaviours) and sleep -- self report; LPA and MVPA -- waist-worn accelerometersBMIMekary et al. \[[@CR12]\] / 30 minAge, sex, snacking habit of the child, parental education, parental BMI, and marital status.β (95% CI)\
Screen time ↔ academic-related activities: − 0.00 (− 0.06, 0.06)\
Screen time ↔ other SBs: − 0.12 (− 0.20, − 0.04)\
Screen time ↔ sleep: − 0.03 (− 0.13, 0.06)\
Screen time ↔ LPA: − 0.05 (− 0.12, 0.02)\
Screen time ↔ MVPA: − 0.42 (− 0.59, − 0.24)\
Academic-related activities ↔ other SBs: − 0.13 (− 0.21, − 0.04)\
Academic-related activities ↔ sleep: − 0.04 (− 0.14, 0.06)\
Academic-related activities ↔ LPA: − 0.05 (− 0.12, 0.02)\
Academic-related activities ↔ MVPA: − 0.42 (− 0.60, − 0.24)\
Other SBs ↔ academic-related activities: 0.13 (0.04, 0.21)\
Other SBs ↔ sleep: 0.09 (− 0.03, 0.20)\
Other SBs ↔ LPA: 0.07 (− 0.02, 0.16)\
Other SBs ↔ MVPA: − 0.30 (− 0.49, − 0.10)\
Sleep ↔ academic-related activities: 0.04 (− 0.06, 0.14)\
Sleep ↔ other SBs: − 0.09 (− 0.20, 0.03)\
Sleep ↔ LPA: − 0.01 (− 0.12, 0.10)\
Sleep ↔ MVPA: − 0.38 (− 0.59, − 0.18)\
LPA ↔ academic-related activities: 0.05 (− 0.02, 0.12)\
LPA ↔ other SBs: − 0.07 (− 0.16. 0.02)\
LPA ↔ sleep: 0.01 (− 0.10 to 0.12)\
LPA ↔ MVPA: − 0.37 (− 0.57, − 0.16)\
MVPA ↔ academic-related activities: 0.42 (0.24, 0.60)\
MVPA ↔ other SBs: 0.30 (0.10, 0.49)\
MVPA ↔ sleep: 0.38 (0.18, 0.59)\
MVPA ↔ LPA: 0.37 (0.16, 0.57)Leppänen et al. \[[@CR63]\]Four year old children (*n* = 307) from the MINISTOP trial, Sweden; cross-sectionalSleep, SB, LPA, MPA, VPA -- wrist-worn accelerometersFFMIMekary et al. \[[@CR12]\] / 5 minMaternal BMI and educational attainment, paternal BMI and educational attainment, child's age and sex at the measurement and awake wearing time of the ActiGraph. Waist circumference was adjusted for height.β (95% CI)\
FFMI\
SB ↔ LPA: − 0.01 (− 0.04, 0.02)\
SB ↔ MPA: 0.01 (− 0.02, 0.04)\
SB ↔ VPA: 0.17 (0.04, 0.30)\
LPA ↔ MPA: 0.02 (− 0.03, 0.08)\
LPA ↔ VPA: 0.18 (0.05, 0.30)\
MPA ↔ VPA: 0.16 (0.01, 0.31)Leppänen et al. \[[@CR27]\]Four year old children (*n* = 138) from the MINISTOP trial, Sweden; prospective cohortSleep, SB, LPA, MPA, VPA -- wrist-worn accelerometersBMI, FMI, FFMI, body fat percentage, waist circumferenceMekary et al. \[[@CR12]\] / 5 minChild's age, sex at measurement, awake wearing time, models with SB or MPA as exposures were adjusted for VPA, while models with VPA or MVPA were adjusted for SB.Reallocating 5 min from SB to LPA or MPA to VPA at baseline was associated with an increase in FFMI and BMI.Loprinzi et al. \[[@CR65]\]Children (*n* = 1036) and adolescents (*n* = 1608) from the 2003--2006 National Health and Nutrition Examination Survey, USA; prospective cohortSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedBMI, waist circumference, triceps and subscapularis skinfold, sex specific android body fat percent, gynoid body fat percent, total body fat percentMekary et al. \[[@CR12]\] / 60 minAge, sex, race-ethnicity, energy intake, poverty-to-income ratio, cotinine, and accelerometer wear time.β (95% CI)\
BMI\
SB ↔ LPA: − 0.18 (− 0.53, 0.16)\
SB ↔ MVPA: − 1.20 (− 1.60, − 0.79)\
LPA ↔ MVPA: − 1.01 (− 1.57, − 0.45)\
BMI Percentile\
SB ↔ LPA: 0.17 (− 2.60, 2.95)\
SB ↔ MVPA: − 7.33 (− 11.88, − 2.78)\
LPA ↔ MVPA: − 7.50 (− 12.53, − 2.47)\
Waist circumference\
SB ↔ LPA: − 0.55 (− 1.50, 0.38)\
SB ↔ MVPA: − 3.81 (− 5.09, − 2.54)\
LPA ↔ MVPA: − 3.25 (− 4.91, − 1.59)\
Triceps skinfold\
SB ↔ LPA: − 0.13 (− 0.70, 0.43)\
SB ↔ MVPA: − 2.54 (− 3.30, − 1.78)\
LPA ↔ MVPA: − 2.40 (− 3.31, − 1.49)\
Subscapularis skinfold\
SB ↔ LPA: − 0.36 (− 0.80, 0.08)\
SB ↔ MVPA: − 1.66 (− 2.37, − 0.95)\
LPA ↔ MVPA: − 1.30 (− 1.97, − 0.63)\
Android body fat percent\
SB ↔ LPA: − 0.28 (− 1.59, 1.02)\
SB ↔ MVPA: − 6.62 (− 8.80, − 4.45)\
LPA ↔ MVPA: − 6.34 (− 9.40, − 3.27)\
Gynoid body fat percent\
SB ↔ LPA: − 0.07 (− 0.87, 0.71)\
SB ↔ MVPA: − 4.40 (− 5.74, − 3.07\
LPA ↔ MVPA: − 4.32 (− 6.11, − 2.54)\
Total body fat percent (standard error)\
SB ↔ LPA: − 0.27 (0.58)\
SB ↔ MVPA: − 4.62 (0.77)\
LPA ↔ MVPA: − 4.34 (0.89)Mekary et al. \[[@CR12]\]Adult women (*n* = 4558) from the Nurses' Health Study II, USA; prospective cohortTV watching, easy walking, average walking, brisk walking, running, other activities, total activity -- self report; sleep -- not assessedWeight changeMekary et al. \[[@CR12]\] / 30 minBaseline age, weight, height, alcohol intake, sugar-sweetened beverage intake, energy-adjusted trans-fat intake, energy-adjusted fibre intake, oral contraceptive use, parity and antidepressant use.β (95% CI)\
TV watching ↔ slow walking: − 1.02 (− 1.55, − 0.48)\
TV watching ↔ brisk walking: − 2.16 (− 2.64, − 1.68)\
TV watching ↔ running: − 3.73 (− 4.89, \_2.57)\
TV watching ↔ other activities: − 1.73 (− 2.13, − 1.33)\
TV watching ↔ total activity: 0.47 (0.36, 0.59)\
Slow walking ↔ brisk walking: − 1.14 (− 1.75, − 0.53)\
Slow walking ↔ running: − 2.71 (− 3.97, − 1.45)\
Slow walking ↔ other activities: − 0.72 (− 1.39, − 0.04)\
Slow walking ↔ total activity: − 0.54 (− 1.07, − 0.02)\
Brisk walking ↔ running: − 1.57 (− 2.82, − 0.33)\
Brisk walking ↔ other activities: 0.43 (− 0.22, 1.07)\
Brisk walking ↔ total activity: − 1.69 (− 2.15, − 1.22)\
Running ↔ other activities: 2.00 (0.77, 3.22)\
Running ↔ total activity: − 3.26 (− 4.41, − 2.10)\
Other activities ↔ total activity: − 1.26 (− 1.65, − 0.87)Mekary et al. \[[@CR68]\]Adult men (n = 10,500) from the Health Professionals Follow-Up Study, USA; prospective cohortTV watching, MVPA (aerobic activity), weight training, other activities; sleep -- self reportWaist circumferenceMekary et al. \[[@CR12]\] / 20 minBaseline age and waist circumference total average alcohol intake, sugar-sweetened beverage intake, percent energy of trans-fat, energy-adjusted fibres, energy-adjusted glycemic load, smoking, antidepressant Intake, percent energy of protein intake, sleep duration, slow walking in addition to TV watching, MVPA, weight training, and other activities.β (95% CI)\
TV watching ↔ MVPA (aerobic activity): −0.42 (− 0.50, − 0.34)\
TV watching ↔ weight training: − 0.76 (− 1.02, − 0.50)\
TV watching ↔ other activities: − 0.24 (− 0.37, − 0.11)\
TV watching ↔ total discretionary time: 0.08 (0.05, 0.12)\
MVPA (aerobic activity) ↔ weight training: − 0.34 (− 0.62, − 0.07)\
MVPA (aerobic activity) ↔ other activities: 0.17 (0.03, 0.31)\
MVPA (aerobic activity) ↔ total discretionary time: − 0.33 (− 0.39, − 0.26)\
Weight training ↔ other activities: 0.52 (0.23, 0.80)\
Weight training ↔ total discretionary time: − 0.67 (− 0.93, − 0.41)\
Other activities ↔ total discretionary time: − 0.15 (− 0.28, − 0.03)Moore et al. \[[@CR28]\]Youth (*n* = 11,588) from the International Children's Accelerometry Database, Brazil, Europe, and USA; cross-sectionalSB, LPA, MPA, VPA -- waist-worn accelerometers; sleep -- not assessedWaist circumferenceMekary et al. \[[@CR12]\] / not presentedAccelerometer cut points.Reallocating LPA with VPA was associated with a 0.67 to 7.30 cm smaller waist circumference at the 50th to 90th percentilesNilsson et al. \[[@CR29]\]Older woman (*n* = 113) recruited from an newspaper ad, Sweden; cross-sectionalSB (accumulated, continuous), LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedWaist circumferenceMekary et al. \[[@CR12]\] / 10 minMedical history, self-rated health status, total energy intake, fat intake, and alcohol consumption.β (95% CI)\
Waist circumference\
MVPA → LPA: 2.19 (1.45, 2.93)\
MVPA → accumulated SB: 1.78 (1.04, 2.57)\
MVPA → continuous SB: 2.08 (1.35, 2.8)Rosique-Esteban et al. \[[@CR32]\]Adults (*n* = 5776) from the PREDIMED-PLUS trial, Spain; cross-sectionalSleep, SB, LPA, MVPA -- self reportPrevalence of obesity, abdominal obesityMekary et al. \[[@CR12]\] / 60 minAge, sex, education, marital and employment status, smoking habits, personal and family history of illness, medical conditions, medication use, and adherence to an energy-restricted Mediterranean diet.RR (95% CI)\
Obesity\
MVPA → sleep: 0.95 (0.93, 0.97)\
MVPA → TV-viewing: 0.92 (0.90, 0.94)\
MVPA → LPA: 0.96 (0.93, 0.99)\
LPA → sleep: 0.98 (0.95, 1.01)\
LPA → TV-viewing: 0.95 (0.92, 0.98)\
Sleep → TV-viewing: 0.97 (0.96, 0.98)\
Abdominal obesity\
MVPA → sleep: 0.97 (0.96, 0.98)\
MVPA → TV-viewing: 0.97 (0.96, 0.98)\
MVPA → LPA: 0.97 (0.96, 0.98)\
LPA → sleep: 1.01 (0.99, 1.03)\
LPA → TV-viewing: 0.99 (0.98, 1.00)\
Sleep → TV-viewing: 0.99 (0.98, 1.00)Sardinha et al. \[[@CR70]\]Children (*n* = 386) from the Lisbon Metropolitan area, Portugal; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedBMI, waist circumference, TFMI, total body fat massMekary et al. \[[@CR12]\] / 15, 30 minAge, sex, accelerometer wear time and in the prospective analysis results were further adjusted for baseline body composition.β (95% CI)\
30 min reallocation\
Cross-sectional analysis\
BMI\
SB → LPA: 0.03 (− 0.09, 0.12)\
SB → MVPA: − 0.21 (− 0.39, − 0.03)\
Waist circumference\
SB → LPA: 0.21 (− 0.81, 1.23)\
SB → MVPA: − 1.32 (− 3.06, 0.42)\
TFMI\
SB → LPA: − 0.09 (− 0.36, 0.15)\
SB → MVPA: − 0.81 (− 12.60, − 0.36)\
Total body fat mass\
SB → LPA: − 0.27 (− 0.78, 0.27)\
SB → MVPA: -1.62 (− 2.52, − 0.69)\
Prospective analyses\
BMI\
SB → LPA: 0.03 (− 0.06, 0.09)\
SB → MVPA: − 0.06 (− 0.18, 0.06)\
Waist circumference\
SB → LPA: − 0.21 (− 0.87, 0.45)\
SB → MVPA: − 1.11 (− 2.16, − 0.06)\
TFMI\
SB → LPA: 0.03 (− 0.09, 0.15)\
SB → MVPA: − 0.21 (− 0.39, 0.00)\
Total body fat mass\
SB → LPA: 0.09 (− 0.15, 0.33)\
SB → MVPA: − 0.48 (− 0.87, − 0.06)\
15 min reallocation\
Cross-sectional analysis\
BMI\
SB → LPA: 0.02 (− 0.05, 0.06)\
SB → MVPA: − 0.11 (− 0.20, − 0.02)\
Waist circumference\
SB → LPA: 0.11 (− 0.41, 0.62)\
SB → MVPA: − 0.66 (− 1.53, 0.21)\
TFMI\
SB → LPA: − 0.05 (− 0.18, 0.08)\
SB → MVPA: − 0.41 (− 6.30, − 0.18)\
Total body fat mass\
SB → LPA: − 0.14 (− 0.39, 0.14)\
SB → MVPA: − 0.81 (− 1.26, − 0.35)\
Prospective analyses\
BMI\
SB → LPA: 0.02 (− 0.03, 0.05)\
SB → MVPA: − 0.03 (− 0.09, 0.03)\
Waist circumference\
SB → LPA: − 0.11 (− 0.44, 0.23)\
SB → MVPA: − 0.56 (− 1.08, − 0.03)\
TFMI\
SB → LPA: 0.02 (− 0.05, 0.08)\
SB → MVPA: − 0.11 (− 0.20, 0.00)\
Total body fat mass\
SB → LPA: 0.05 (− 0.08, 0.17)\
SB → MVPA: − 0.24 (− 0.44, − 0.03)Van der Berg et al. \[[@CR35]\]Adults (*n* = 2213) from The Maastricht Study, Netherlands; cross-sectionalSB, standing, stepping -- thigh-worn accelerometers; sleep -- not assessedWaist circumference, BMIMekary et al. \[[@CR12]\] / 30 minAge, sex, level of education, smoking status, alcohol consumption, energy intake, mobility limitation, and prevalent cardiovascular diseaseOR (95% CI)\
Waist circumference\
SB → standing: − 0.405 (− 0.60, − 0.21)\
SB → stepping: − 1.422 (− 1.78, − 1.06)\
Standing → stepping: − 1.017 (− 1.47, − 0.56)\
BMI\
SB → standing: − 0.038 (− 0.11, 0.03)\
SB → stepping: − 0.480 (− 0.62, − 0.35)\
Standing → stepping: − 0.443 (− 0.61, − 0.27)Varela-Mato et al. \[[@CR37]\]Adult male heavy goods vehicle drivers (n = 87), from a transport company from the East Midlands, UK; cross-sectionalSB, standing and stepping (LPA, MVPA) -- thigh-worn accelerometers; sleep -- estimated from the accelerometers and matched with the participants' daily logWaist circumference, BMIMekary et al. \[[@CR12]\] / 30 minAge, ethnicity, education levels, shift pattern, smoking, alcohol intake, fruit and vegetable consumption and BMI.β (95% CI)\
Workdays\
Waist Circumference\
SB → standing: − 0.1 (− 1.4, 1.2)\
SB → LPA: − 0.6 (− 3.9, 2.7)\
SB → MVPA: − 6.5 (− 11.0, − 1.9)\
SB → sleep: 0.1 (− 0.3, 0.5)\
BMI\
SB → standing: 0.07 (− 0.4, 0.6)\
SB → LPA: − 0.7 (− 1.9, 0.5)\
SB → MVPA: − 1.5 (− 3.2, 0.2)\
SB → sleep: − 0.0 (− 0.2, 0.1)\
Non-workdays\
Waist Circumference\
SB → standing: − 0.4 (− 1.2, 2.1)\
SB → LPA: 0.4 (− 1.3, 2.1)\
SB → MVPA: − 0.8 (− 4.8, 3.2)\
SB → sleep: − 0.4 (− 1.1, 0.5)\
BMI\
SB → standing: 0.1 (− 0.5, 0.2)\
SB → LPA: − 0.2 (− 0.8, 0.4)\
SB → MVPA: 0.2 (− 1.2, 1.7)\
SB → sleep: − 0.3 (− 0.5,--0.05)*SB* sedentary behaviour, *LPA* light intensity physical activity, *MVPA* moderate-to-vigorous intensity physical activity, *MPA* moderate intensity physical activity, *VPA* vigorous intensity physical activity; *BMI* body mass index, *HDL* high-density lipoprotein, *CVD* cardiovascular disease*, FFM* fat-free mass, *TFMI* trunk fat mass index, *FFMI* fat-free mass index, *FMI* fat mass index, *CRF* cardiorespiratory fitness, *IMD* indices of multiple deprivation, *CI* confidence interval, *RR* relative risk, *OR* odds ratioTable 5Summary of the findings from the studies assessing fitness outcomesStudySample and study designMeasures of sleep, SB, LPA, MVPAOutcome measuresData analysis method / reallocated timeAdjustments for confoundingResultsAggio et al. \[[@CR44]\]Children and youth (*n* = 353) from the Camden Active Spaces project, UK; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedHand grip strength, horizontal jump distance, flexibility, peak expiratory flowMekary et al. \[[@CR12]\] / 60 minAge, sex, ethnicity, height and school deprivation.β (95% CI)\
Hand grip strength\
SB ↔ LPA: 0.509 (0.000, 1.019)\
SB ↔ MVPA: 0.511 (− 1.139, 2.161)\
LPA ↔ MVPA: 0.002 (− 1.760, 1.763)\
Horizontal jump distance\
SB ↔ LPA: 0.409 (− 2.252, 3.070)\
SB ↔ MVPA: 16.093 (7.476, 24.710)\
LPA ↔ MVPA: 15.684 (6.484, 24.885)\
Peak expiratory flow\
SB ↔ LPA: − 0.149 (− 7.569, 7.298)\
SB ↔ MVPA: 5.389 (− 18.728, 29.506)\
LPA ↔ MVPA: 5.538 (− 20.210, 31.287)\
Flexibility\
SB ↔ LPA: − 0.048 (− 0.935, 0.839)\
SB ↔ MVPA: 4.783 (1.910, 7.656)\
LPA ↔ MVPA: 4.831 (1.764, 7.899)Collings et al. \[[@CR20]\]Children (*n* = 410) from the Physical Activity and Nutrition in Children study, Finland; cross-sectionalSleep, SB, LPA, MPA, VPA -- heart rate and movement sensorCRFMekary et al. \[[@CR12]\] / 10 minAge, sex, monitor wear characteristics, income, sleep duration, energy intake, frequency of breakfast consumption, number of meals per day, snacking, birth weight, maternal and paternal BMI. When FMI, TFMI and FFMI were outcomes further adjustment for CRF was made. CRF was adjusted for FMI.β (95% CI)\
SB → LPA: − 0.0038 (− 0.010, 0.0027)\
SB → MPA: 0.014 (0.0064, 0.022)\
SB → VPA: 0.098 (0.040, 0.16)\
LPA → MPA: 0.018 (0.0054, 0.031)\
LPA → VPA: 0.10 (0.046, 0.16)\
MPA → VPA: 0.083 (0.024, 0.14)Ekblom-Bak et al. \[[@CR52]\]Adults (*n* = 654) from the Swedish Cardio Pulmonary bioImage Study, Sweden; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedVO2maxMekary et al. \[[@CR12]\] / 1, 5, 10, 15, 20, 25, 30, 60, 90 and 120 minSex, age, education, smoking, perceived psychosocial stress.OR (95% CI)\
30 min reallocation\
VO2max (women \< 32 and men \< 35 ml·min-1·kg-1)\
SB → LPA: 0.953 (0.926, 0.982)\
SB → MVPA: 0.870 (0.794, 0.953)\
VO2max (women ≥32 and men ≥35 ml·min-1·kg-1)\
SB → LPA: 0.989 (0.966, 1.013)\
SB → MVPA: 0.904 (0.851, 0.960)Fairclough et al. \[[@CR25]\]Children (*n* = 169) from the Active Schools Skelmersdale study, UK; cross-sectionalSB, LPA, MVPA -- wrist-worn accelerometers; sleep -- estimated from the ActiGraph raw accelerationsCRFDumuid et al. \[[@CR14]\] / 15 minIMD decile, age, sex, and BMI.Reallocating 15 min from MVPA to sleep, SB or LPA predicted higher adiposity and lower CRF.\
Reallocating time to MVPA from sleep, SB or LPA increased the magnitude of estimated detriments for fitness and adiposity. Furthermore, the detriments were larger in magnitude than the estimated benefits of time reallocation from MVPA to sleep, SB or LPA.Kim \[[@CR61]\]Older woman (*n* = 101), from the Itabashi ward, metropolitan Tokyo, Japan; cross-sectionalSB (prolonged SB and non-prolonged SB), LPA, MVPA -- wrist-worn accelerometers; sleep -- not assessedUsual gait speed, maximum gait speed, 5-chair sit-to-stand, and timed up-and-go testsMekary et al. \[[@CR12]\] / 30 minAge, BMI, education, living conditions, smoking, alcohol consumption, number of medical conditions, and Tokyo metropolitan institute of gerontology score.β (95% CI)\
Usual walking speed\
Prolonged SB → non-prolonged SB: 0.013 (− 0.017, 0.043)\
Prolonged SB → LPA: − 0.032 (− 0.076, 0.013)\
Prolonged SB → MVPA: 0.240 (0.133, 0.346)\
Non-prolonged SB → LPA: − 0.045 (− 0.090, 0.000)\
Non-prolonged SB → MVPA: 0.226 (0.120, 0.332)\
LPA → MVPA: 0.271 (0.137, 0.405)\
Maximum walking speed\
Prolonged SB → non-prolonged SB: − 0.010 (− 0.049, 0.030)\
Prolonged SB → LPA: − 0.052 (− 0.108, 0.004)\
Prolonged SB → MVPA: 0.240 (0.0105, 0.375)\
Non-prolonged SB → LPA: − 0.043 (− 0.099, 0.013)\
Non-prolonged SB → MVPA: 0.250 (0.116, 0.383)\
LPA → MVPA: 0.292 (0.124, 0.460)\
5 chair sit-to-stand\
Prolonged SB → non-prolonged SB: 0.298 (− 0.031, 0626)\
Prolonged SB → LPA: − 0.024 (− 0.496, 0.447)\
Prolonged SB → MVPA: − 0.960 (− 2.130, 0.209)\
Non-prolonged SB → LPA: − 0.322 (− 0.802, 0.158)\
Non-prolonged SB → MVPA: − 1.258 (− 2.417, − 0.098)\
LPA → MVPA: − 0.937 (− 2.397, 0.522)\
Timed Up and Go\
Prolonged SB → non-prolonged SB: − 0.468 (− 0.824, − 0.112)\
Prolonged SB → LPA: − 0.065 (− 0.591, 0.461)\
Prolonged SB → MVPA: − 2.264 (− 3.557, − 0.970)\
Non-prolonged SB → LPA: 0.404 (− 0.128, 0.935)\
Non-prolonged SB → MVPA: − 1.796 (− 3.082, − 0.510)\
LPA → MVPA: − 2.199 (− 3.816, − 0.581)Leppänen et al. \[[@CR63]\]Four year old children (*n* = 307) from the MINISTOP trial, Sweden; cross-sectionalSleep, SB, LPA, MPA, VPA -- wrist-worn accelerometers20-m shuttle run test, handgrip strength, standing long jump test and a 4 × 10-m shuttle run testMekary et al. \[[@CR12]\] / 5 minMaternal BMI and educational attainment, paternal BMI and educational attainment, child's age and sex at the measurement and awake wearing time of the ActiGraph.β (95% CI)\
20-m shuttle run test\
SB ↔ LPA: −  0.05 (− 0.12, 0.03)\
SB ↔ MPA: 0.01 (− 0.08, 0.10)\
SB ↔ VPA: 0.87 (0.53, 1.22)\
LPA ↔ MPA: 0.06 (− 0.08, 0.20)\
LPA ↔ VPA: 0.92 (0.59, 1.25)\
MPA ↔ VPA: 0.86 (0.47, 1.26)\
Handgrip strength\
SB ↔ LPA: − 0.00 (− 0.05, 0.04)\
SB ↔ MPA: 0.03 (− 0.02, 0.09)\
SB ↔ VPA: 0.17 (− 0.04, 0.38)\
LPA ↔ MPA: 0.04 (− 0.05, 0.12)\
LPA ↔ VPA: 0.17 (− 0.03, 0.38)\
MPA ↔ VPA: 0.14 (− 0.10, 0.38)\
Standing long jump\
SB ↔ LPA: − 0.46 (− 0.90, − 0.02)\
SB ↔ MPA: 0.40 (− 0.14, 0.94)\
SB ↔ VPA: 2.09 (0.01, 4.17)\
LPA ↔ MPA: 0.86 (0.00, 1.71)\
LPA ↔ VPA: 2.55 (0.53, 4.56)\
MPA ↔ VPA: 1.68 (− 0.74, 4.10)\
4 × 10 m-shuttle run\
SB ↔ LPA: 0.03 (− 0.03, 0.08)\
SB ↔ MPA: − 0.00 (− 0.07, 0.07)\
SB ↔ VPA: − 0.62 (− 0.88, − 0.36)\
LPA ↔ MPA: − 0.03 (− 0.13, 0.08)\
LPA ↔ VPA: − 0.65 (− 0.90, − 0.40)\
MPA ↔ VPA: − 0.62 (− 0.92, − 0.32)Leppänen et al. \[[@CR27]\]Four year old children (*n* = 138) from the MINISTOP trial, Sweden; prospective cohortSleep, SB, LPA, MPA, VPA -- wrist-worn accelerometers20-m shuttle run test, handgrip strength, standing long jump test and a 4 × 10-m shuttle run testMekary et al. \[[@CR12]\] / 5 minChild's age, sex at measurement, awake wearing time, models with SB or MPA as exposures were adjusted for VPA, while models with VPA or MVPA were adjusted for SB.Reallocating 5 min from SB to LPA or MPA to VPA at baseline was associated with a better handgrip strength and with longer jumps at 12-month follow-up.Van der Velde et al. \[[@CR36]\]Adults (*n* = 2024) from The Maastricht Study, Netherlands; cross-sectionalSB, standing, LPA, MVPA -- thigh-worn accelerometers; sleep -- not assessedCRFMekary et al. \[[@CR12]\] / 60 minAge, education level, type 2 diabetes, BMI, alcohol use, smoking status, cardio vascular disease, beta-blocker use, energy intake and mobility limitationsβ (95% CI)\
Men\
SB → standing: 0.01 (− 0.02, 0.04)\
SB → LPA: 0.08 (0.03, 0.14)\
SB → MVPA: 0.49 (0.39, 0.59)\
Women\
SB → standing: − 0.00 (− 0.02, 0.02)\
SB → LPA: 0.10 (0.05, 0.16)\
SB → MVPA: 0.28 (0.19, 0.36)*SB* sedentary behaviour, *LPA* light intensity physical activity, *MVPA* moderate-to-vigorous intensity physical activity, *MPA* moderate intensity physical activity, *VPA* vigorous intensity physical activity, *BMI* body mass index, *CRF* cardiorespiratory fitness, *VO2max* maximal oxygen consumption, *IMD* indices of multiple deprivation, *CI* confidence interval, *OR* odds ratioTable 6Summary of the findings from the studies assessing biomarkersStudySampleMeasures of sleep, SB, LPA, MVPAOutcome measuresData analysis method / reallocated timeAdjustments for confoundingResultsBuman et al. \[[@CR48]\]Adults (*n* = 2185 -- full sample; *n* = 923 -- fasting sub-sample) from the 2005--2006 US National Health and Nutrition Examination Survey, USA; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- self reportSystolic and diastolic blood pressure, HDL, C-reactive protein, LDL, plasma glucose, insulin, triglycerides, HOMA-S, HOMA-βMekary et al. \[[@CR12]\] / 30 minSex, race, marital status, education, work status, income, smoking, depressive symptoms, 24-h dietary recalls estimating intakes of total energy, saturated fat, caffeine, and alcohol, a general health rating, diagnosis of cancer, malignancy, CVD, or diabetes, and current use of diabetic, antihypertensive, lipidemic, or other CVD medication.RR (95% CI)\
HDL cholesterol\
Sleep → MVPA: 1.044 (1.019, 1.070)\
SB → MVPA: 1.046 (1.028, 1.065)\
LPA → MVPA: 1.043 (1.023, 1.064)\
Sleep → LPA: 1.001 (0.994, 1.008)\
SB → LPA: 1.003 (0.998, 1.008)\
SB → sleep: 1.002 (0.994, 1.011)\
Triglycerides\
Sleep → MVPA: 0.915 (0.851, 0.983)\
SB → MVPA: 0.914 (0.855, 0.977)\
LPA → MVPA: 0.931 (0.869, 0.998)\
Sleep → LPA: 0.983 (0.964, 1.002)\
SB → LPA: 0.981 (0.972, 0.991)\
SB → sleep: 0.999 (0.982, 1.016)\
Insulin\
Sleep → MVPA: 0.893 (0.803, 0.994)\
SB → MVPA: 0.874 (0.786, 0.970)\
LPA → MVPA: 0.895 (0.801, 1.000)\
Sleep → LPA: 0.998 (0.969, 1.029)\
SB → LPA: 0.976 (0.962, 0.991)\
SB → sleep: 0.978 (0.957, 1.000)Carson et al. \[[@CR49]\]Children and youth aged 6--17 years (*n* = 4169 -- full sample; *n* = 1242 -- fasting sub-sample) from the Canadian Health Measures Survey, Canada; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- self reportBMI, waist circumference, blood pressure, behavioural strengths and difficulties, CRF -- full sample. Triglycerides,\
HDL, C-reactive protein, and insulin -- fasting subsample.Chastin et al. \[[@CR13]\] / 10 minAge, sex, and highest household education.Reallocating 10 min of MVPA to SB, LPA or sleep, resulted in a 5.1, 1.2, and 1.1% increase in BMI z score, respectively.\
Reallocating 10 min of SB, LPA or sleep, to MVPA resulted in a less than 1% decrease in BMI z score.\
Similar effects were noted across all health indicators.Chastin et al. \[[@CR13]\]Adults (*n* = 1937) from the National Health and Nutrition Examination Survey 2005--2006 cycle, USA; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- self reportBlood pressure, plasma glucose and insulin, HDL, C-reactive protein, LDL, triglyceridesMekary et al. \[[@CR12]\] / 10 minAge, sex, ethnicity/race, self-reported health, diagnosis of health conditions, educational level, social economic status, smoking status, alcohol consumption, calorie intake, caffeine and fat, medications for diabetes and/or high blood pressure.Reallocating 10 min of LPA or MVPA to sleep was associated with positive effects on systolic and diastolic blood pressure.\
Reallocating 10 min of sleep to MVPA was associated with positive effects on HDL.\
Reallocating 10 min of MVPA with sleep was associated with positive effects on C-reactive protein.\
Reallocating 10 min of MVPA with sleep or SB was associated with detrimental effects on LDL, triglycerides, glucose and insulin level and HOMA. Similar, but smaller effects were noted when 10 min of SB was reallocated to LPA or sleep.\
Reallocating 10 min of MVPA to sleep or LPA had a detrimental effect on both obesity markers, with stronger magnitude when LPA replaced MVPA.\
Reallocating 10 min of SB or sleep to LPA was associated with more favourable effects on LDL, triglycerides, glucose, insulin, and HOMA. The effects were more pronounced when 10 min of LPA replaced sleep than SB.Edwardson et al. \[[@CR24]\]Adults identified as being at high risk of impaired glucose regulation (*n* = 435) from the Walking Away from Diabetes randomized controlled trial, UK; cross-sectionalSB, standing, stepping -- thigh-worn accelerometers; sleep -- not assessedFasting glucose, 2-h glucose, fasting insulin, 2-h insulin, HOMA-IS, Matsuda-ISIMekary et al. \[[@CR12]\] / 30 minAge, sex, smoking status, family history of type 2 diabetes, ethnicity, β-blockers, lipid-lowering medication and activPAL waking wear time (model 1), and waist circumference (model 2).β (95% CI)\
Model 1\
Fasting glucose\
Prolonged SB → short SB: 1.00 (0.99, 1.00)\
Prolonged SB → standing: 1.00 (0.99, 1.01)\
Prolonged SB → stepping: 0.98 (0.97, 0.99)\
Short SB → standing: 1.00 (0.99, 1.01)\
Short SB → stepping: 0.99 (0.98, 1.00)\
2-h glucose\
Prolonged SB → short SB: 0.99 (0.97, 1.01)\
Prolonged SB → standing: 1.00 (0.98, 1.01)\
Prolonged SB → stepping: 0.94 (0.92, 0.97)\
Short SB → standing: 1.00 (0.99, 1.00)\
Short SB → stepping: 0.95 (0.92, 0.97)\
Fasting insulin\
Prolonged SB → short SB: 0.96 (0.93, 0.99)\
Prolonged SB → standing: 0.95 (0.92, 0.98)\
Prolonged SB → stepping: 0.89 (0.84, 0.95)\
Short SB → standing: 0.98 (0.95, 1.01)\
Short SB → stepping: 0.93 (0.88, 0.98)\
2-h insulin\
Prolonged SB → short SB: 0.97 (0.92, 1.02)\
Prolonged SB → standing: 0.94 (0.90, 0.99)\
Prolonged SB → stepping: 0.85 (0.78, 0.92)\
Short SB → standing: 0.98 (0.94, 1.02)\
Short SB → stepping: 0.87 (0.81, 0.93)\
HOMA-IS\
Prolonged SB → short SB: 1.04 (1.01, 1.07)\
Prolonged SB → standing: 1.06 (1.02, 1.10)\
Prolonged SB → stepping: 1.15 (1.06, 1.26)\
Short SB → standing: 1.02 (0.99, 1.05)\
Short SB → stepping: 1.10 (1.03, 1.17)\
Matsuda-ISI\
Prolonged SB → short SB: 1.03 (0.99, 1.07)\
Prolonged SB → standing: 1.06 (1.01, 1.11)\
Prolonged SB → stepping: 1.22 (1.09, 1.35)\
Short SB → standing: 1.02 (0.99, 1.06)\
Short SB → stepping: 1.17 (1.07, 1.27)\
Model 2\
Fasting glucose\
Prolonged SB → short SB: 1.00 (0.99, 1.01)\
Prolonged SB → standing: 1.00 (0.99, 1.01)\
Prolonged SB → stepping: 0.99 (0.98, 1.00)\
Short SB → standing: 1.00 (0.99, 1.01)\
Short SB → stepping: 1.00 (0.98, 1.01)\
2-h glucose\
Prolonged SB → short SB: 0.99 (0.97, 1.01)\
Prolonged SB → standing: 1.00 (0.98, 1.02)\
Prolonged SB → stepping: 0.95 (0.92, 0.98)\
Short SB → standing: 1.00 (0.99, 1.00)\
Short SB → stepping: 0.95 (0.93, 0.98)\
Fasting insulin\
Prolonged SB → short SB: 0.96 (0.94, 0.98)\
Prolonged SB → standing: 0.96 (0.93, 0.99)\
Prolonged SB → stepping: 0.93 (0.88, 0.98)\
Short SB → standing: 0.99 (0.96, 1.02)\
Short SB → stepping: 0.96 (0.92, 1.00)\
2-h insulin\
Prolonged SB → short SB: 0.97 (0.92, 1.02)\
Prolonged SB → standing: 0.95 (0.91, 1.00)\
Prolonged SB → stepping: 0.87 (0.80, 0.94)\
Short SB → standing: 0.99 (0.95, 1.03)\
Short SB → stepping: 0.90 (0.83, 0.98)\
HOMA-IS\
Prolonged SB → short SB: 1.04 (1.01, 1.07)\
Prolonged SB → standing: 1.04 (1.01, 1.07)\
Prolonged SB → stepping: 1.09 (1.01, 1.17)\
Short SB → standing: 1.00 (0.97, 1.03)\
Short SB → stepping: 1.05 (0.99, 1.11)\
Matsuda-ISI\
Prolonged SB → short SB: 1.03 (0.98, 1.08)\
Prolonged SB → standing: 1.05 (1.01, 1.09)\
Prolonged SB → stepping: 1.16 (1.05, 1.28)\
Short SB → standing: 1.01 (0.96, 1.05)\
Short SB → stepping: 1.12 (1.03, 1.22)Ekblom-Bak et al. \[[@CR51]\]Adults (*n* = 836) from the Swedish Cardio Pulmonary bioImage Study, Sweden; cross-sectionalSB, LPA, MPA, VPA -- waist-worn accelerometers; sleep -- not assessedTriglyceride levels, HDL, blood pressure and glucose levels.Mekary et al. \[[@CR12]\] / 1, 5, 10, 15, 20, 25, 30, 60, 90 and 120 minAge, sex, education level, smoking habits, perceived psychological stress, energy intake and wear time.OR (95% CI)\
10-min reallocation\
High triglyceride levels\
SB → LPA: 0.97 (0.94, 0.99)\
SB → MPA: 0.91 (0.83, 0.99)\
SB → VPA: 0.51 (0.33, 0.79)\
Low HDL\
SB → LPA: 0.95 (0.92, 0.98)\
SB → MPA: 0.91 (0.82, 1.01)\
SB → VPA: 0.34 (0.18, 0.65)\
High blood pressure\
SB → LPA: 1.00 (0.97, 1.02)\
SB → MPA: 0.92 (0.85, 0.99)\
SB → VPA: 0.77 (0.58, 1.04)\
High glucose\
SB → LPA: 0.99 (0.97, 1.01)\
SB → MPA: 0.97 (0.91, 1.03)\
SB → VPA: 0.88 (0.73, 1.07)Ekblom-Bak et al. \[[@CR52]\]Adults (*n* = 654) from the Swedish Cardio Pulmonary bioImage Study, Sweden; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedSystolic and diastolic blood pressure, glucose, triglycerides, HDLMekary et al. \[[@CR12]\] / 1, 5, 10, 15, 20, 25, 30, 60, 90 and 120 minSex, age, education, smoking, perceived psychosocial stress.RR (95% CI)\
30 min reallocation\
Fasting glucose\
SB → LPA: 0.998 (0.995, 1.001)\
SB → MVPA: 0.991 (0.983, 0.999)\
Fasting insulin\
SB → LPA: 0.970 (0.954, 0.987)\
SB → MVPA: 0.884 (0.844, 0.927)\
HOMA-IR\
SB → LPA: 0.969 (0.951, 0.987)\
SB → MVPA: 0.876 (0.832, 0.923)\
Fasting glucose (\<  6.0 mmol·l-1)\
SB → LPA: 0.980 (0.961, 0.999)\
SB → MVPA: 0.894 (0.846, 0.945)\
Fasting glucose (≥ 6.0 mmol·l-1)\
SB → LPA: 0.937 (0.906, 0.969)\
SB → MVPA: 0.889 (0.818, 0.967)\
Reallocating 5 to 120 min from SB to MVPA was associated with positive effects\
HOMA-IR (for participants with lower waist circumferences) and across all time lengths for participants with higher waist circumferences.\
Reallocating 1 to 120 min from SB to LPA or MVPA was associated with positive effects on HOMA-IR levels (for participants with low fitness).\
Reallocating 1 to 120 min from SB to MVPA was associated with positive effects\
HOMA-IR levels (for participants with high levels of fitness).\
Reallocating 1 to 120 min from SB to LPA or MVPA was associated with positive effects on HOMA-IR levels (for participants with high glucose levels).\
Reallocating 1 to 120 min from SB to MVPA was associated with positive effects\
HOMA-IR levels (for participants with normal glucose levels).Falconer et al. \[[@CR53]\]Adults with type 2 diabetes (*n* = 519) from the Early Activity in Diabetes study, UK; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedHDLMekary et al. \[[@CR12]\] / 30 minAge, sex, ethnic group, IMD score, accelerometer wear time, relevant diabetes or lipid-lowering drugs.β (95% CI)\
HDL\
SB bouts → SB nonbouts: 0.01 (− 0.02, 0.03)\
SB bouts → LPA: 0.02 (0.01, 0.03)\
SB bouts → MVPA: 0.03 (− 0.01, 0.08)\
SB nonbouts → LPA: 0.01 (− 0.01, 0.04)\
SB nonbouts → MVPA: 0.03 (− 0.02, 0.07)\
LPA → MVPA: 0.02 (− 0.03, 0.06)Hamer et al. \[[@CR56]\]Adults (*n* = 445) from the Whitehall II epidemiological cohort, UK; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedHDL-C, triglycerides, HbA1cMekary et al. 2009 / 10 minAge, sex, smoking, employment grade, and current statin use.β (95% CI)\
HbA1c\
SB ↔ LPA: 0.001 (0.006, − 0.009)\
SB ↔ MVPA: − 0.023 (− 0.043, − 0.002)\
LPA ↔ MVPA: − 0.024 (− 0.047, − 0.001)\
HDL-C\
SB ↔ LPA: 0.005 (− 0.001, 0.01)\
SB ↔ MVPA: 0.037 (0.021, 0.054)\
LPA ↔ MVPA: 0.032 (0.014, 0.050)\
Triglycerides\
SB ↔ LPA: − 0.004 (− 0.014, 0.006)\
SB ↔ MVPA: − 0.035 (− 0.061, − 0.009)\
LPA ↔ MVPA: − 0.031 (− 0.060, − 0.002)Healy et al. \[[@CR58]\]A general population-based sample (*n* = 698) from the 2011/12 Australian Diabetes, Obesity, and Lifestyle Study, Australia; cross-sectionalSB, standing, stepping -- thigh-worn accelerometers; sleep -- self reportFasting glucose, HDL, LDL, total/HDL-cholesterol ratio, triglycerides and 2-h plasma glucose.Mekary et al. \[[@CR12]\] / 120 minAge, sex, contraceptive pill use, blood pressure tablets, cholesterol tablets, diabetes medication, ethnicity, occupation and employment status, income, fibre intake, energy intake, energy-adjusted fibre intake, alcohol intake, sodium intake, potassium intake, fruit and vegetable serves.RR (95% CI)\
Fasting glucose\
Sitting → standing: 0.98 (0.97, 1.00)\
Sitting → stepping: 0.98 (0.95, 1.02)\
Standing → stepping: 1.00 (0.97, 1.04)\
β (95% CI)\
HDL\
Sitting → standing: 0.06 (0.02, 0.09)\
Sitting → stepping: 0.10 (0.02, 0.18)\
Standing → stepping: 0.04 (− 0.05, 0.14)\
RR (95% CI)\
Total/HDL-cholesterol ratio\
Sitting → standing: 0.94 (0.92, 0.97)\
Sitting → stepping: 0.97 (0.92, 1.03)\
Standing → stepping: 1.04 (0.97, 1.11)\
RR (95% CI)\
Triglycerides\
Sitting → standing: 0.90 (0.87, 0.94)\
Sitting → stepping: 0.88 (0.78, 0.98)\
Standing → stepping: 0.98 (0.86, 1.11)\
RR (95% CI)\
2-h plasma glucose\
Sitting → standing: 0.99 (0.96, 1.02)\
Sitting → stepping: 0.89 (0.84, 0.94)\
Standing → stepping: 0.90 (0.84, 0.97)Healy et al. \[[@CR57]\]Individuals with diagnosed type 2 diabetes (*n* = 279) from the Living Well with Diabetes intervention, Australia; cross-sectionalSB (prolonged SB and non-prolonged SB), LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedFasting plasma glucoseMekary et al. \[[@CR12]\] / 30 minAge, sex, BMI, waist circumference, log HbA1c, insulin use, oral hypoglycaemic use, use of glucagon-like-peptide-1 agents, diabetes duration, income, education, weight loss aids in last 6 months, smoking status, CVD-related condition, musculoskeletal condition, depression and/or anxiety, employment, place of birth, Caucasian, energy intake, diet quality score.RR (95% CI)\
Fasting blood glucose\
Prolonged SB → non-prolonged SB: 1.01 (0.99, 1.03)\
Prolonged SB → LPA: 0.99 (0.97, 1.00)\
Prolonged SB → MVPA: 0.96 (0.90, 1.03)\
Non-prolonged SB → LPA: 0.98 (0.96, 1.00)\
Non-prolonged SB → MVPA: 0.96 (0.89, 1.02)\
LPA → MVPA: 0.98 (0.91, 1.05)Moore et al. \[[@CR28]\]Youth (*n* = 11,588) from the International Children's Accelerometry Database, Brazil, Europe, and USA; cross-sectionalSB, LPA, MPA, VPA -- waist-worn accelerometers; sleep -- not assessedDiastolic blood pressure, systolic blood pressure, HDL, LDL, glucose, insulin, triglyceridesMekary et al. \[[@CR12]\] / not presentedAccelerometer cut points.Reallocating LPA with VPA was inconsistently related to blood pressure, fasting triglycerides, HDL, or LDL with only 32 of a possible 360 associations statistically significant.\
Reallocating LPA with VPA was associated with 12.6 to 27.0 pmol/l lower insulin values at the 75th to 90th percentiles.Nilsson et al. \[[@CR29]\]Older woman (*n* = 113) recruited from an newspaper ad, Sweden; cross-sectionalSB (accumulated, continuous), LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedTriglycerides, HDL, plasma glucose, and blood pressureMekary et al. \[[@CR12]\] / 10 minMedical history, self-rated health status, total energy intake, fat intake, and alcohol consumption.β (95% CI)\
Clustered metabolic risk score\
MVPA → LPA: 0.06 (0.01, 0.10)\
MVPA → accumulated SB: 0.07 (0.02, 0.11)\
MVPA → continuous SB: 0.08 (0.04, 0.13)\
Clustered metabolic risk score adjusted for waist circumference\
MVPA → LPA: 0.02 (− 0.02, 0.07)\
MVPA → accumulated SB: 0.04 (− 0.01, 0.09)\
MVPA → continuous SB: 0.05 (0.01, 0.10)Rosique Esteban et al. \[[@CR32]\]Adults (*n* = 5776) from the PREDIMED-PLUS trial, Spain; cross-sectionalSleep, SB, LPA, MVPA -- self reportBlood pressure, hyperglycaemia, hypertriglyceridemia, HDLMekary et al. \[[@CR12]\] / 60 minAge, sex, education, marital and employment status, smoking habits, personal and family history of illness, medical conditions, medication use, and adherence to an energy-restricted Mediterranean diet.RR (95% CI)\
Blood pressure\
MVPA → sleep: 0.99 (0.98, 1.00)\
MVPA → TV-viewing: 1.01 (0.99, 1.03)\
MVPA → LPA: 0.99 (0.98, 1.00)\
LPA → sleep: 1.00 (0.99, 1.01)\
LPA → TV-viewing: 1.00 (0.99, 1.01)\
Sleep → TV-viewing: 0.99 (0.97, 1.01)\
Hyperglycaemia\
MVPA → sleep: 0.98 (0.95, 1.01)\
MVPA → TV-viewing: 0.98 (0.96, 1.00)\
MVPA → LPA: 0.96 (0.93, 0.99)\
LPA → sleep: 1.02 (0.99, 1.05)\
LPA → TV-viewing: 1.02 (0.99, 1.05)\
Sleep → TV-viewing: 1.00 (0.98, 1.02)\
Hypertriglyceridemia\
MVPA → sleep: 0.94 (0.89, 0.99)\
MVPA → TV-viewing: 0.94 (0.90, 0.98)\
MVPA → LPA: 0.95 (0.88, 1.02)\
LPA → sleep: 0.99 (0.93, 1.05)\
LPA → TV-viewing: 0.97 (0.91, 1.03)\
Sleep → TV-viewing: 0.98 (0.95, 1.01)\
Low HDL\
MVPA → sleep: 0.92 (0.87, 0.97)\
MVPA → TV-viewing: 0.94 (0.90, 0.98)\
MVPA → LPA: 0.92 (0.86, 0.98)\
LPA → sleep: 0.97 (0.90, 1.04)\
LPA → TV-viewing: 0.99 (0.93, 1.05)\
Sleep → TV-viewing: 1.03 (1.00, 1.06)Van der Berg et al. \[[@CR35]\]Adults (*n* = 2213) from The Maastricht Study, Netherlands; cross-sectionalSB, standing, stepping -- thigh-worn accelerometers; sleep -- not assessedHDL, total-to-HDL cholesterol ratio, triacylglycerol, 2 h post-load glucose, fasting insulinMekary et al. \[[@CR12]\] / 30 minAge, sex, level of education, smoking status, alcohol consumption, energy intake, mobility limitation, and prevalent cardiovascular diseaseOR (95% CI)\
HDL\
SB → standing: 0.005 (0.00, 0.01)\
SB → stepping: 0.041 (0.03, 0.05)\
Standing → stepping: 0.036 (0.02, 0.05)\
Total-to-HDL cholesterol ratio\
SB → standing: 0.993 (0.99, 1.00)\
SB → stepping: 0.981 (0.97, 0.99)\
Standing → stepping: 0.988 (0.98, 1.00)\
Triacylglycerol\
SB → standing: 0.991 (0.98, 1.00)\
SB → stepping: 0.975 (0.96, 0.99)\
Standing → stepping: 0.984 (0.97, 1.00)\
2 h post-load glucose\
SB → standing: 0.999 (1.00, 1.00)\
SB → stepping: 0.981 (0.97, 0.99)\
Standing → stepping: 0.982 (0.97, 0.99)\
Fasting insulin\
SB → standing: 0.987 (0.98, 1.00)\
SB → stepping: 0.970 (0.95, 0.99)\
Standing → stepping: 0.983 (0.96, 1.01)Varela-Mato et al. \[[@CR37]\]Adult male heavy goods vehicle drivers (*n* = 87), from a transport company from the East Midlands, UK; cross-sectionalSB, standing and stepping (LPA, MVPA) -- thigh-worn accelerometers; sleep -- estimated from the accelerometers and matched with the participants' daily logSystolic blood pressure, Diastolic blood pressure, fasting glucose, triglycerides, HDL, LDL, total cholesterolMekary et al. \[[@CR12]\] / 30 minAge, ethnicity, education levels, shift pattern, smoking, alcohol intake, fruit and vegetable consumption and BMI.β (95% CI)\
Workdays\
Systolic blood pressure\
SB → standing: 0.6 (− 0.6, 1.9)\
SB → LPA: − 1.9 (− 5.1, 1.3)\
SB → MVPA: − 1.1 (− 5.5, 3.3)\
SB → sleep: − 0.3 (− 0.4, 0.4)\
Diastolic blood pressure\
SB → standing: 0.6 (− 0.5, 1.7)\
SB → LPA: − 1.8 (− 4.7, 0.9)\
SB → MVPA: 0.1 (− 3.8, 4.0)\
SB → sleep: − 0.2 (− 0.5, 0.2)\
Fasting glucose\
SB → standing: − 0.01 (− 0.1, 0.1)\
SB → LPA: − 0.04 (− 0.3, 0.2)\
SB → MVPA: − 0.3 (− 0.6, 0.1)\
SB → sleep: − 0.04 (− 0.1, 0.02)\
Triglycerides\
SB → standing: 0.00 (− 0.1, 0.1)\
SB → LPA: 0.06 (− 0.2, 0.3)\
SB → MVPA: − 0.4 (− 0.8, 0.01)\
SB → sleep: 0.02 (− 0.01, 0.05)\
HDL\
SB → standing: − 0.02 (− 0.06, 0.01)\
SB → LPA: − 0.1 (− 0.2, − 0.01)\
SB → MVPA: 0.3 (0.1, 0.4)\
SB → sleep: − 0.01 (− 0.02, 0.01)\
LDL\
SB → standing: − 0.04 (− 0.2, 0.1)\
SB → LPA: 0.2 (− 0.1, 0.6)\
SB → MVPA: − 0.1 (− 0.6, 0.5)\
SB → sleep: − 0.02 (− 0.07, 0.02)\
Total cholesterol\
SB → standing: − 0.6 (− 0.07, 0.02)\
SB → LPA: 0.1 (− 0.2, 0.5)\
SB → MVPA: 0.05 (− 0.4, 0.6)\
SB → sleep: − 0.2 (− 0.07, 0.02)\
Non-workdays\
Systolic blood pressure\
SB → standing: − 0.3 (− 1.1, 0.5)\
SB → LPA: 0.3 (− 1.3, 1.9)\
SB → MVPA: − 0.01 (− 3.7,3.7)\
SB → sleep: − 0.6 (− 1.2, 0.1)\
Diastolic blood pressure\
SB → standing: − 0.5 (− 1.2, 0.2)\
SB → LPA: − 0.5 (− 1.9, 0.9)\
SB → MVPA: 0.3 (− 2.9, 3.6)\
SB → sleep: − 0.3 (− 0.9, 0.2)\
Fasting glucose\
SB → standing: 0.01 (− 0.07, 0.1)\
SB → LPA: 0.03 (− 0.1, 0.2)\
SB → MVPA: − 0.3 (− 0.7, 0.05)\
SB → sleep: − 0.00 (− 0.06, 0.06)\
Triglycerides\
SB → standing: − 0.03 (− 0.1,0.04)\
SB → LPA: 0.07 (− 0.07, 0.2)\
SB → MVPA: − 0.2 (− 0.5, 1.0)\
SB → sleep: − 0.02 (− 0.08, 0.04)\
HDL\
SB → standing: 0.02 (− 0.01,0.05)\
SB → LPA: − 0.05 (− 0.1, 0.01)\
SB → MVPA: 0.07 (− 1.0, 0.2)\
SB → sleep: 0.0 (− 0.02, 0.03)\
LDL\
SB → standing: − 0.08 (− 0.2,0.01)\
SB → LPA: 0.0 (− 0.2, 0.2)\
SB → MVPA: − 0.01 (− 0.5, 0.4)\
SB → sleep: − 0.04 (− 0.2, 0.04)\
Total cholesterol\
SB → standing: − 0.08 (− 0.2,0.02)\
SB → LPA: − 0.03 (− 0.2, 0.1)\
SB → MVPA: 0.03 (− 0.4, 0.5)\
SB → sleep: − 0.03 (− 0.1, 0.04)Wang et al. \[[@CR74]\]Individuals (*n* = 1699) with diabetes mellitus from the Hispanic Community Health Study/Study of Latinos (2008--2011), USA; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedBlood pressure, HbA1c, LDL, HDL, and triglycerides.Mekary et al. \[[@CR12]\] / 30, 60 minAge, sex, annual household income, education, employment status, Hispanic/Latino background, field centre, smoking, alcohol consumption, duration of Diabetes mellitus, health insurance status, alternative health eating index-2010, self-reported physical health score, and use of antidiabetic, antihypertensive, and lipid-lowering medications.OR (95% CI)30 min\
HbA1c\
SB → MVPA: 1.06 (0.89, 1.25)\
Blood pressure\
SB → MVPA: 1.27 (1.04, 1.55)\
LDL\
SB → MVPA: 0.94 (0.79, 1.12)\
HDL\
SB → MVPA: 0.95 (0.81, 1.13)\
Triglycerides\
SB → MVPA: 0.91 (0.76, 1.09)\
60 min\
HbA1c\
SB → LPA: 1.18 (1.04, 1.35)\
Blood pressure\
SB → LPA: 1.03 (0.91, 1.18)\
LDL\
SB → LPA: 1.04 (0.89, 1.22)\
HDL\
SB → LPA: 1.17 (1.04, 1.32)\
Triglycerides\
SB → LPA: 1.20 (1.05, 1.36)Whitaker et al. \[[@CR38]\]Adults (*n* = 3211) from the CARDIA study, USA; cross-sectionalSB including \[i\] TV viewing, \[ii\] using the computer for non-work activities or playing video games, \[iii\] doing non-computer office work or paperwork, \[iv\] listening to music, reading a book or magazine, or doing arts and crafts, \[v\] talking on the phone or texting, and \[vi\] sitting in a car, bus, train or other mode of transportation, MVPA -- self reports; LPA, sleep -- not assessedComposite cardio metabolic risk scoreMekary et al. \[[@CR12]\] / 120 minAge, sex, centre, race, education, unemployment, health insurance, smoking, alcohol, total physical activity, fast food and sugar sweetened beverage consumption, depressive symptoms and BMI.β (95% CI)\
Composite cardio metabolic risk score\
TV viewing ↔ computer usage: − 0.07 (− 0.11, − 0.03)\
TV viewing ↔ paperwork: − 0.07 (− 0.12, − 0.02)\
TV viewing ↔ reading: 0.06 (− 0.11, − 0.02)\
TV viewing ↔ talking on the phone: − 0.07 (− 0.12, − 0.02)\
TV viewing ↔ sitting in a car: − 0.09 (− 0.13, − 0.05)\
Computer usage ↔ paperwork: − 0.00 (− 0.06, 0.06)\
Computer usage ↔ reading: 0.01 (− 0.04, 0.05)\
Computer usage ↔ talking on the phone: − 0.00 (− 0.06, 0.05)\
Computer usage ↔ sitting in a car: − 0.02 (− 0.06, 0.02)\
Paperwork ↔ reading: 0.01 (− 0.05, 0.06)\
Paperwork ↔ talking on the phone: − 0.00 (− 0.06, 0.06)\
Paperwork ↔ sitting in a car: − 0.02 (− 0.07, 0.04)\
Reading ↔ talking on the phone: − 0.01 (− 0.07, 0.05)\
Reading ↔ sitting in a car: − 0.03 (− 0.07, 0.02)\
Talking on the phone ↔ sitting in a car: − 0.02 (− 0.07, 0.04)Yates et al. \[[@CR76]\]Adults at increased risk of type 2 diabetes (*n* = 508) from the Walking Away from Type 2 Diabetes Study, UK; cross-sectionalSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedFasting and 2-h post-challenge insulin and glucose, HOMA-IS and Matsuda-ISIMekary et al. \[[@CR12]\] / 30 minAge, sex, smoking status, beta-blocker and statin medication status, IMD score (model 1) and BMI (model 2).OR (95% CI)\
Model 1\
Fasting glucose\
SB → LPA: 1.00 (0.99, 1.01)\
SB → MVPA: 1.00 (0.98, 1.01)\
Fasting insulin\
SB → LPA: 0.98 (0.95, 1.01)\
SB → MVPA: 0.87 (0.81, 0.93)\
2-h glucose\
SB → LPA: 0.97 (0.95, 0.99)\
SB → MVPA: 0.98 (0.95, 1.02)\
2-h insulin\
SB → LPA: 0.96 (0.92, 1.00)\
SB → MVPA: 0.84 (0.76, 0.92)\
HOMA-IS\
SB → LPA: 1.02 (0.98, 1.05)\
SB → MVPA: 1.15 (1.07, 1.25)\
Matsuda-ISI\
SB → LPA: 1.05 (1.01, 1.09)\
SB → MVPA: 1.18 (1.08, 1.29)\
Model 2\
Fasting glucose\
SB → LPA: 1.00 (0.99, 1.01)\
SB → MVPA: 1.00 (0.98, 1.02)\
Fasting insulin\
SB → LPA: 0.99 (0.96, 1.02)\
SB → MVPA: 0.92 (0.86, 0.99)\
2-h glucose\
SB → LPA: 0.97 (0.95, 0.99)\
SB → MVPA: 0.98 (0.94, 1.02)\
2-h insulin\
SB → LPA: 0.96 (0.91, 1.00)\
SB → MVPA: 0.85 (0.77, 0.94)\
HOMA-IS\
SB → LPA: 1.01 (0.97, 1.04)\
SB → MVPA: 1.08 (1.01, 1.16)\
Matsuda-ISI\
SB → LPA: 1.04 (1.00, 1.08)\
SB → MVPA: 1.14 (1.04, 1.25)*SB* sedentary behaviour, *LPA* light intensity physical activity, *MVPA* moderate-to-vigorous intensity physical activity, *MPA* moderate intensity physical activity, *VPA* vigorous intensity physical activity, *BMI* body mass index, *HDL* high-density lipoproteins, *LDL* low-density lipoproteins, *HOMA-S* homeostasis model assessment of insulin sensitivity, *HOMA*-*β* homeostasis model assessment of β-cell function, *CVD* cardiovascular disease, *Mastuda-ISI* matsuda-insulin sensitivity index, *HbA1c* glycated haemoglobin, *RR* relative risk, *CI* confidence interval, *OR* odds ratioTable 7Summary of the findings from studies that assessed chronic diseases and conditionsStudySampleMeasures of sleep, SB, LPA, MVPAOutcome measuresData analysis method / reallocated timeAdjustments for confoundingResultsBoeke et al. \[[@CR46]\]Women (*n* = 75,669) from the Nurses' Health Study II, USA; prospective cohortLPA, MPA, VPA -- self-report; sleep, SB -- not assessedBreast cancerMekary et al. \[[@CR12]\] / not presentedAge, height, age at menarche, oral contraceptive history, reproductive history, alcohol intake, body size at ages 10 and 20 years, weight, new pregnancies, breastfeeding duration, oral contraceptive and postmenopausal hormone use, menopausal status, age at menopause, and benign breast disease diagnosis.No individual values were reported.Ekblom-Bak et al. \[[@CR51]\]Adults (*n* = 836) from the Swedish Cardio Pulmonary bioImage Study, Sweden; cross-sectionalSB, LPA, MPA, VPA -- waist-worn accelerometers; sleep -- not assessedMetabolic syndrome prevalenceMekary et al. \[[@CR12]\] / 1, 5, 10, 15, 20, 25, 30, 60, 90 and 120 minAge, sex, education level, smoking habits, perceived psychological stress, energy intake and wear time.OR (95% CI)\
10-min reallocation\
Metabolic syndrome\
SB → LPA: 0.96 (0.93, 0.98)\
SB → MPA: 0.89 (0.82, 0.97)\
SB → VPA: 0.42 (0.26, 0.67)\
Reallocating 1 to 120 min from SB to LPA or MPA was associated with a decrease in metabolic syndrome prevalence.\
Reallocating 1 to 60 min from SB to VPA was associated with a decrease in metabolic syndrome prevalence.Pinto et al. \[[@CR30]\]Adults with an increased risk for developing knee osteoarthritis (*n* = 1794) from the sub-cohort of the Osteoarthritis Initiative, USA; prospective cohortSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedQuality-adjusted life yearMekary et al. \[[@CR12]\] / 60 minAge, sex, race/ethnicity, education, marriage status, income and BMI.Reallocating 60 min from SB to MVPA was associated with an improvement in the quality-adjusted life year. Reallocating 60 min from SB to LPA did not result in any significant changes.Rosique-Esteban et al. \[[@CR32]\]Adults (*n* = 5776) from the PREDIMED-PLUS trial, Spain; prospective cohortSleep, SB, LPA, MVPA -- self reportPrevalence of type 2 diabetesMekary et al. \[[@CR12]\] / 60 minAge, sex, education, marital and employment status, smoking habits, personal and family history of illness, medical conditions, medication use, and adherence to an energy-restricted Mediterranean diet.RR (95% CI)\
Type 2 diabetes\
MVPA → sleep: 0.95 (0.89, 1.01)\
MVPA → TV-viewing: 0.91 (0.86, 0.96)\
MVPA → LPA: 0.92 (0.85, 0.99)\
LPA → sleep: 1.03 (0.96, 1.10)\
LPA → TV-viewing: 1.00 (0.93, 1.07)\
Sleep → TV-viewing: 0.96 (0.93, 0.99)Ryan et al. \[[@CR33]\]Adults (*n* = 2313) from the 2008 Health Survey for England, UK; prospective cohortSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedChronic musculoskeletal painMekary et al. \[[@CR12]\] / 10, 30 minAge, sex, BMI, socioeconomic status, diet, smoking history, alcohol intake, anxiety/depression, and presence of a non-musculoskeletal long-standing illness.PR (95% CI)\
SB → LPA: 1.01 (0.99, 1.02)\
SB → MVPA: 0.90 (0.82, 0.98)\
In the secondary analysis reallocating 30 min of SB to MVPA resulted in relative risk reduction of 29%.Wellburn et al. \[[@CR75]\]Adults (*n* = 1327) from the 2008 Health Survey for England, UK; prospective cohortSB, LPA, MVPA -- waist-worn accelerometers; sleep -- not assessedPrevalence of cardiovascular diseaseMekary et al. \[[@CR12]\] / 10, 20 minAge, sex, smoking status, socioeconomic status, diet, alcohol intake, anxiety/depression, musculoskeletal medication. Model 1 was adjusted for age alone, model 2 for age and sex and model 3 for all covariates.RR (95% CI)\
10 min\
Model 1\
SB → LPA: 0.97 (0.95, 0.98)\
SB → MVPA: 0.89 (0.82, 0.96)\
Model 2\
SB → LPA: 0.97 (0.96, 0.99)\
SB → MVPA: 0.87 (0.81, 0.94)\
Model 3\
SB → LPA: 0.97 (0.96, 0.99)\
SB → MVPA: 0.88 (0.81, 0.96)\
20 min\
SB → LPA: 0.95 (0.92, 0.98)*SB* sedentary behaviour, *LPA* light intensity physical activity, *MVPA* moderate-to-vigorous intensity physical activity, *MPA* moderate intensity physical activity, *VPA* vigorous intensity physical activity, *BMI* body mass index, *OR* odds ratio, *CI* confidence interval, *RI* relative risk, *PR* prevalence ratio

Methodological quality {#Sec12}
----------------------

The average score on the Newcastle-Ottawa scale for cross-sectional studies was 6, while the individual scores ranged from 5 to 8 points. Nine of the cross-sectional studies were classified as being of high quality, while 29 were appraised as being of moderate quality. The average score for prospective cohort studies was also 6, with the individual scores ranging from 4 to 8 points. Ten of the studies were classified as being of high quality, and the remaining ten were classified as being of moderate methodological quality. The methodological quality appraisal result for cross-sectional and prospective cohort studies can be found in Additional files [2](#MOESM2){ref-type="media"} and [3](#MOESM3){ref-type="media"}, respectively.

Discussion {#Sec13}
==========

This is the first review of health outcomes associated with reallocations of time between movement-related behaviours, compiling available evidence for all previously studied health outcomes across all age groups. The number of publications using ISM for health outcomes is increasing each year. Most commonly studied health outcomes in relation to isotemporal substitutions were mortality, general health, mental health, adiposity, fitness, and cardiometabolic biomarkers. The Mekary et al. \[[@CR12]\] model has been by far the most often used method for investigating health outcomes of isotemporal substitution, but it is has also been available for the longest period of time. Findings from studies using ISM are of great value as they contribute evidence for the construction of meaningful recommendations for increasing physical activity, reducing sedentary behaviour, and optimizing sleep duration, by taking into account all the behaviours across the energy expenditure spectrum, and not just focusing on one behaviour in isolation from the others.

Mortality {#Sec14}
---------

The current body of literature suggests that high sedentary time and low MVPA are predictive of premature mortality \[[@CR8], [@CR77]\]. When analysing data from the 2003--2006 US National Health and Nutrition Examination Survey (NHANES), Fishman et al. \[[@CR54]\] concluded that reallocating 30 min/day of sedentary time with LPA reduced mortality risk by 20% over a five-year follow-up period. One study reported a 13% reduction in mortality risk when substituting 30 min/day of sedentary time with LPA \[[@CR65]\]. The study found that replacement of the same amount of sedentary time with MVPA would reduce the mortality risk by as much as 81%. In addition to total volume, it seems therefore that physical activity intensity may play an important role in reducing the risk of premature mortality.

In a large-scale epidemiological study, Stamatakis et al. \[[@CR72]\] reported beneficial associations on reducing the mortality risk when total sitting time was replaced with standing, walking, or MVPA. The study also considered sleep duration and indicated that reallocating 60 min/day of sedentary time to sleep may reduce the risk of mortality by 6%. However, this was found to be relevant only among individuals that reported sleeping fewer than seven hours per day.

When reallocating sedentary time to physical activity, Matthews et al. \[[@CR66]\] reported a greater reduction in mortality risk for less active (\< 2 h of total activity per day), than for more active (≥ 2 h of total activity per day) individuals. Follow-up work from the same group found that replacing one hour of sedentary time with LPA reduced mortality risk by 18% \[[@CR67]\]. The reduction in mortality risk was more than doubled (42%) when sedentary time was reallocated to MVPA. In their analysis of the UK Biobank data, Wijndaele et al. \[[@CR39]\] found that the substitution of 30 min/day of screen time with strenuous sports was associated with 15% reduction in the mortality risk. While in this study strenuous sports provided the most substantial associations, it is important to note that replacing screen time with 30 min/day of walking, also resulted in a considerable decrease in mortality risk (5%). Schmid et al. \[[@CR71]\] reported that replacing 30 min/day of sedentary time with an equal amount of LPA or MVPA is associated with a 14 and 50% reduction in mortality risk, respectively. The same authors also found that replacing 30 min/day of sedentary time with LPA resulted in an 8% reduction in the risk of cancer mortality. The plausibility of these large estimated reductions in mortality risk needs to be confirmed in future studies.

Most of the evidence is currently focused on reallocations of time from sedentary behaviour to some intensity band of physical activity (e.g., LPA or MVPA). However, there is a lack of evidence on reallocating time spent in sedentary behaviour to standing. This might be because most devices for tracking physical activity, such as waist-worn accelerometers, are not able to differentiate between sedentary behaviour and standing. Furthermore, most questionnaires do not include questions regarding posture during certain types of typically sedentary activities, such as watching TV and inactive transport \[[@CR1]\]. It is, therefore, unclear whether participants sat or stood while engaging in such activities. Nonetheless, one study suggested that replacing sedentary behaviour with standing might reduce the risk of premature mortality \[[@CR72]\]. More such research seems to be needed to inform evidence-based decisions on the use of sit-stand desks and other methods for displacement of sitting with standing in the office setting. Given the increasing popularity of sit-stand desks, findings from these studies may have significant practical implications.

To summarise, it seems that reallocations of sedentary behaviour to LPA or MVPA are associated with significant reduction in mortality risk. Current evidence seems to consistently suggest that reductions in mortality risk are greater when time spent sedentary is replaced with higher intensities of physical activity. However, the generalizability of these findings remains limited, because the studies were conducted only in Australia \[[@CR72]\], UK \[[@CR39]\], and US \[[@CR50], [@CR54], [@CR62], [@CR65]--[@CR67], [@CR71]\]. There is no evidence for low and middle-income countries. Furthermore, most studies did not include sleep duration in their analysis. Due to the significant impact of sleep duration on health and its co-dependence on other components of time use, future studies should aim to include sleep duration in their ISMs along with all the remaining movement behaviours.

Perceived/general health status {#Sec15}
-------------------------------

Studies that assessed perceived/general health status were conducted among adults, older adults, and clinical populations. No studies were conducted among youth.

### Adults/older adults {#Sec16}

Health-related quality of life (HRQoL) is an indicator of general health emanating from the individual perception of the impact that diseases have on different areas of life \[[@CR45]\]. Loprinzi and Loenneke \[[@CR65]\] investigated the impact of time reallocation between movement behaviours on HRQoL among adults using data from 2003 to 2006 NHANES. The study reported that substituting sedentary behaviour with LPA or MVPA was associated with improved HRQoL, suggesting the need for strategies to promote increasing physical activity at the expense of sedentary behaviour. Further support for such findings comes from Buman et al. \[[@CR47]\] who found that replacing sedentary time with equal amounts of LPA or MVPA was associated with better self-reported physical health.

### Clinical populations {#Sec17}

Among clinical populations, Van Roekel et al. \[[@CR73]\] reported improvements in some aspects of HRQoL to be associated with the replacement of sedentary time with standing, LPA or MVPA in a group of colorectal cancer survivors. Vallance et al. \[[@CR34]\] investigated these relationships in a group of non-Hodgkins lymphoma survivors and found that reallocating sedentary time, sleep, or LPA to MVPA was associated with lower levels of fatigue, but not with improved quality of life. Studies like the one performed by Vallance et al. \[[@CR34]\] are needed as non-Hodgkin lymphoma survivors and many other clinical populations exhibit higher levels of fatigue and poorer general health compared to non-clinical populations \[[@CR78]\], and participating in physical activity appears to improve these health aspects \[[@CR79]\].

While there are several studies exploring aspects of perceived general health using ISM, more evidence is needed on this topic. This lack of empirical evidence opens up an avenue for future studies, specifically studies including older adults and clinical populations. Only two of the included studies that assessed perceived general health included sleep in their ISMs, which is a key limitation of the current body of evidence.

Mental health {#Sec18}
-------------

Studies that assessed mental health were conducted among youth, adults, and older adults. No studies were conducted among clinical populations.

### Youth {#Sec19}

Janssen \[[@CR60]\] investigated the associations of reallocating time between playing sedentary video games, playing active video games, and engaging in outdoor activities with mental health indicators among youth (mean age: 14.1 years; range 13.9--14.4 years). The results indicated that replacing time spent playing sedentary video games with playing active video games may be associated with more positive psychological outcomes, including indicators such as emotional problems, life satisfaction, and prosocial behaviours \[[@CR60]\]. It should be noted that replacing active outdoor play with active video games was associated with the probability of high emotional problems, a reduced probability of high prosocial behaviour and high life satisfaction. The study supports active video games over sedentary video games; however, for the most positive mental health results, time spent on video games should be replaced with active outdoor play \[[@CR60]\].

### Adults/older adults {#Sec20}

Depressive disorders are one of the most common mental health issues and affect around 10% of the adult population in the USA \[[@CR80]\]. Previous studies have suggested that physical inactivity may be a risk factor for depressive symptoms \[[@CR81]\]. Mekary et al. \[[@CR69]\] reported that reallocating time spent watching TV to walking at a fast pace may be protective against depression. However, this was not found for reallocating time to walking at a slower pace, reinforcing the potential importance of higher intensities of physical activity. Rethorst et al.'s \[[@CR31]\] study supports the importance of physical activity intensity as they noted that replacing sedentary time with VPA was associated with a significant decrease in depressive symptoms. However, the same was not observed for replacing sedentary time with LPA or MPA. Due to the scarcity of studies using ISMs while assessing mental health outcomes, further evidence on the topic is warranted.

Adiposity {#Sec21}
---------

Studies assessing adiposity were conducted among youth, adults, older adults, and clinical individuals.

### Youth {#Sec22}

Adiposity was the most common outcome assessed in the studies included in this review. Aggio et al. \[[@CR44]\] found that reallocating sedentary time with MVPA was associated with a significant reduction in body fat percentage in children and adolescents (age range: 5--15 years). Further evidence among children was presented by Collings et al. \[[@CR21]\] who found that substituting sedentary time with LPA or MVPA was inversely associated with fat mass index and trunk fat mass index. Moreover, this study reported that the association was stronger when sedentary time was substituted with vigorous physical activity (VPA) than with MVPA. Similar findings were obtained among children in Norway \[[@CR23]\], Sweden \[[@CR27], [@CR63]\], Portugal \[[@CR70]\], and the UK \[[@CR25]\]. Coupled with the conclusions presented in a recent meta-analysis \[[@CR18]\], this evidence highlights the potential importance of substituting sedentary time with physical activity, in particular physical activity at vigorous intensities, to offset unhealthy fat gain in children.

### Adults/older adults {#Sec23}

The associations of ISM with adiposity were also explored in healthy adult populations. Buman et al. \[[@CR48]\] reported a 2.4% lower waist circumference expected when 30 min/day of sedentary time were replaced with MVPA. Similar observations were made by Gupta et al. \[[@CR55]\], who reported significant reductions in multiple obesity indicators, including waist circumference, body fat percentage and body mass index (BMI), associated with reallocating time from sedentary behaviour to standing time or MVPA, with the associations being greater for substitutions with MVPA. The stronger associations observed for substitution of sedentary behaviour with MVPA than with standing are likely because there is not a large difference in energy expenditure between sedentary behaviour and standing, unlike between sedentary behaviour and MVPA \[[@CR82]\]. Beneficial associations between BMI and the reallocation of sedentary time to MVPA were also observed by Chastin et al. \[[@CR13]\], who used a compositional model of isotemporal substitution based on the change-prediction matrix. Reallocating time from TV watching to MVPA was associated with a lower prevalence of obesity in Rosique-Esteban et al. \[[@CR32]\].

### Clinical populations {#Sec24}

ISM has also been used to investigate how reallocations of time are associated with measures of adiposity among clinical populations. Boyle et al. \[[@CR19]\] observed that reallocating time from either sleep, sedentary behaviour, or LPA to MVPA was associated with lower waist circumference and BMI in a group of breast cancer survivors. It is well established that MVPA is beneficial in the prevention and management of T2D \[[@CR83]\]. Studies using accelerometry-derived behaviours found that the majority of individuals with T2D spent a significant portion of the day (63% of the day) in sedentary pursuits, with only 2% of the day spent in MVPA \[[@CR84]\]. As reported by Healy et al. \[[@CR57]\], reducing prolonged sedentary time and replacing it with MVPA was associated with lower waist circumference and BMI in individuals with T2D. Falconer et al. \[[@CR53]\] found that even replacing prolonged bouts of sedentary time with shorter bouts of sedentary time was associated with lower BMI and waist circumference in adults with a recent diagnosis of T2D. While these findings would suggest that replacing sitting time with more 'active' behaviours might have significant health benefits in clinical populations, due to the cross-sectional nature of the studies, the causality of this relationship remains unclear.

In summary, it seems that reallocating sedentary time to physical activity may be associated with reduced BMI, body fat percentage and waist circumference in all populations, with the magnitude of associations being greater for higher intensity activities. However, most studies have not accounted for sleep time, which remains a major limitation in the current body of evidence. It is estimated that \~ 40% of the population reports sleeping less than the recommended minimum of seven hours per night \[[@CR85]\] which may negatively affect health \[[@CR86]\]. Studies have indicated that short sleep duration is associated with increased risk of obesity among children and adults \[[@CR6]\]. Given its co-dependence with sedentary behaviour, LPA, and MVPA, sleep should, when possible, be included in isotemporal substitution models. Further research should track sleep duration in addition to sedentary time and physical activity, to increase the robustness of the findings.

Fitness {#Sec25}
-------

Studies assessing fitness were conducted among youth, adults, and older adults. No such studies were conducted among clinical populations. Higher levels of muscular strength, as well as general and cardiorespiratory fitness, are considered important health markers in children and adolescents \[[@CR87], [@CR88]\]. Higher cardiorespiratory fitness is associated with a lower risk of being overweight or obese in puberty \[[@CR88]\]. In adolescents, higher muscular strength is associated with a lower risk of premature mortality \[[@CR89]\], and participation in resistance training is associated with more favourable body composition in overweight and obese children and adolescents \[[@CR90]\].

### Youth {#Sec26}

When exploring fitness levels among children, Leppänen et al. \[[@CR63]\] found that the reallocation of sedentary behaviour to LPA or MVPA was associated with greater cardiorespiratory fitness, as assessed by the 20-m shuttle run test. The magnitude of the associations was larger when sedentary behaviour was replaced with MVPA, rather than LPA. In a cohort of 10-year-old children, replacing MVPA with any other movement behaviour (i.e., sleep, sedentary time, and LPA) was associated with lower levels of cardiorespiratory fitness \[[@CR25]\]. Therefore, it seems that reallocating sedentary time to LPA or MVPA should be promoted among children.

### Adults/older adults {#Sec27}

At the other end of the age spectrum, in a cohort of aged Japanese woman (age range: 76--89 years), Kim \[[@CR61]\] concluded that reallocating sedentary time to MVPA may improve performance in several measures of fitness, including usual and maximum gait speed, 5-chair sit-to-stand tests, and timed up-and-go test. In their analysis of data from the Maastricht Study, van der Velde et al. \[[@CR36]\] found that replacing sedentary time with LPA was associated with higher cardio-respiratory fitness. The findings seem encouraging and of potentially great importance for individuals who may have difficulties engaging in MVPA. While reallocating sedentary time to LPA was reported to be beneficial for cardio-respiratory fitness, reallocating the same durations of time to MVPA was associated with somewhat greater associations \[[@CR32]\]. Overall, studies suggest likely improvements in fitness when time is reallocated from sedentary behaviour to physical activity. However, an additional evidence is needed to form firm conclusions, particularly among adult and clinical populations.

Cardiometabolic biomarkers {#Sec28}
--------------------------

Studies assessing cardiometabolic biomarkers were conducted among youth, adults, and older adults. There was no available evidence for clinical populations.

### Youth {#Sec29}

Only two studies thus far have used the ISM with cardiometabolic biomarkers as outcome variables \[[@CR28], [@CR49]\]. These studies used two different ISMs, and therefore, the comparability of their findings may be limited. A recent study compared the ISMs by Mekary et al. \[[@CR12]\] and by Dumuid et al. \[[@CR14]\] using the same dataset and reported differences in estimates between the models \[[@CR91]\]. Using the model by Mekary et al. \[[@CR12]\], Moore and colleagues \[[@CR28]\] reported a beneficial associations of reallocating time from LPA to VPA with insulin levels. The association seemed stronger in individuals with higher baseline insulin levels. Carson et al. \[[@CR49]\] employed the compositional ISM described by Chastin et al. \[[@CR13]\] using data from the Canadian Health Measures Survey, with sleep, sedentary behaviour, LPA, and MPA as explanatory variables and systolic and diastolic blood pressure, C-reactive protein, HDL-cholesterol, triglycerides, and insulin level. The established associations were either unclear or practically insignificant. The cross-sectional design of both studies prevented drawing conclusions about causality of the established relationships. Future research is needed to strengthen the evidence base on the association between isotemporal substitutions and cardiometabolic markers in children and adolescents.

### Adults/older adults {#Sec30}

In their study using the 2005--2006 NHANES data, Buman et al. \[[@CR48]\] investigated how reallocating time between sedentary behaviour, sleep, LPA, and MVPA was associated with waist circumference, systolic and diastolic blood pressure, high-density lipoprotein, C-reactive protein, low-density lipoprotein, plasma glucose, insulin, triglycerides, homeostasis model assessment of insulin sensitivity (HOMA-S), and homeostasis model assessment of β-cell function (HOMA-β). They found that reallocation of sedentary behaviour to MVPA was associated with increased levels of high-density lipoprotein cholesterol, and with a decrease in waist circumference, triglycerides, glucose, insulin, and HOMA-S \[[@CR48]\]. Reallocating time from sedentary behaviour to LPA was beneficial for triglycerides, insulin sensitivity, and HOMA-β \[[@CR48]\]. The study also considered sleep duration and reported that reallocating time from sedentary behaviour to sleep was beneficially associated with insulin, HOMA-S, HOMA-β. The same association was found for LDL, albeit only in long sleepers (≥ 8 h of sleep per night). Consistent with studies on other health outcomes, Buman et al. \[[@CR48]\] inferred that the greatest benefits might be expected from increasing MVPA at the expense of other movement behaviours.

Edwardson et al. \[[@CR24]\] reported that reallocation of prolonged sitting to standing or stepping improved 2-h glucose levels, fasting and 2-h insulin levels, and insulin sensitivity in individuals at high risk of impaired glucose regulation or T2D. While modest in terms of magnitudes of associations, the results seem promising for this population. Increasing habitual MVPA levels may be difficult for some individuals and population sub-groups. Evidence from other studies further supports the findings that reallocating sedentary time to LPA (standing and stepping) is associated with more favourable Matsuda-Insulin sensitivity index, levels of high-density lipoprotein \[[@CR48]\], and glycosylated hemoglobin \[[@CR53]\]. Overall, studies indicated that reallocating sedentary time to LPA or MVPA was associated with favourable cardiometabolic outcomes. While there is a relatively large body of evidence regarding associations between time reallocation and cardiometabolic biomarkers among adults, few studies have been conducted among children, adolescents, and older adults. In addition, the studies among older adults were conducted on small sample sizes \[[@CR29]\]. Future studies should employ longitudinal study designs to further investigate associations of isotemporal substitution with fitness-related outcomes.

Chronic diseases and conditions {#Sec31}
-------------------------------

Studies assessing chronic diseases and conditions were conducted among adults and older adults. There was no available evidence for clinical populations.

### Adults/older adults {#Sec32}

In total, six eligible studies were identified. The assessed outcomes included: cardiovascular disease, T2D, metabolic syndrome, breast cancer, chronic musculoskeletal pain, and quality-adjusted life years. Significant associations were found between reallocating time spent in sedentary behaviour to LPA or MVPA and a reduced risk of cardiovascular disease \[[@CR75]\]. Furthermore, reallocation of time from TV-viewing to MVPA was associated with a significantly lower risk of T2D \[[@CR32]\]. Ekblom-Bak et al. \[[@CR51]\] noted that reallocating time from SB to LPA or MPA was associated with a decrease in the risk of metabolic syndrome. For breast cancer, Boeke et al. \[[@CR46]\] found no evidence that substituting MVPA for walking was associated with breast cancer risk. Ryan et al. \[[@CR33]\], reported a 29% relative risk reduction in chronic musculoskeletal pain when reallocating 10 min of sedentary behaviour to MVPA. Evidence on various other chronic disease and conditions is scarce. A study by Pinto and colleagues \[[@CR30]\] assessing quality-adjusted life years indicated that reallocating 60 min from SB to MVPA was associated with a significant improvement in this outcome. The study did not find any evidence that reallocating SB to LPA was associated with quality-adjusted life years. More research is needed about the effects of isotemporal substitutions on chronic diseases and conditions.

Statistical considerations and methodological quality {#Sec33}
-----------------------------------------------------

The ISM introduced by Mekary et al. \[[@CR12]\] represents the first attempt within physical activity and sedentary behaviour research to deal with the constrained nature of time-use variables (i.e., the day only ever has 24 h for every participant), and to account for the fact that one time-use domain cannot be altered without compensatory changes in other time-use domains.

Subsequently, some researchers have suggested that time-use data are compositional data that occupy a constrained sample space and convey relative information \[[@CR1], [@CR2], [@CR13], [@CR14]\]. Accordingly, statistical methods designed for vectors in real space (including the isotemporal substitution model proposed by Mekary et al. \[[@CR12]\], which may, therefore, not be appropriate for time-use data which do not occupy real space \[[@CR1], [@CR2], [@CR13], [@CR14]\]. The compositional isotemporal substitution (based on the change-prediction matrix) presented in Chastin et al. \[[@CR13]\] and later used in Carson et al. \[[@CR47]\] was the first attempt to apply the logic of the Mekary et al. \[[@CR12]\] ISM method in a compositional data analysis framework. The compositional isotemporal approach was subsequently simplified by Dumuid et al. \[[@CR14]\]. There is an ongoing discussion among researchers in the field of epidemiology about which of these methods should preferably be used \[[@CR2], [@CR14]\]. Interested readers can find detailed statistical reasoning about the potential implications of using each of the three methods elsewhere \[[@CR14], [@CR15]\].

It is important to highlight that from a methodological standpoint, all of the included studies were classified as being of high or moderate quality. The findings seem to be generally consistent across the studies, indicating that they were not significantly influenced by differences in study designs. A strength of most included studies is the use of device-based measures for assessing time spent in movement behaviours. Self-reports were used in some large-scale studies, which seems reasonable given accelerometry may significantly add to the administrative burden for researchers \[[@CR92]\]. However, no systematic differences could be observed in the findings from studies relying on self-reports and device-based measures. The majority of the ISM studies used the linear regression model \[[@CR21], [@CR24], [@CR27], [@CR29], [@CR35], [@CR36], [@CR39], [@CR44]--[@CR46], [@CR48], [@CR54], [@CR56], [@CR57], [@CR63], [@CR70], [@CR72], [@CR76]\]. Most of them \[[@CR21], [@CR24], [@CR27], [@CR29], [@CR35], [@CR36], [@CR39], [@CR44]--[@CR46], [@CR48], [@CR54], [@CR56], [@CR57], [@CR63], [@CR70], [@CR72], [@CR76]\] assessed the linearity of the relationships prior to running the ISM analysis and indicated that they were linear. Using compositional data analysis, Dumuid et al. \[[@CR14]\] have shown that associations of isotemporal substitutions with health outcomes may be non-linear and may depend on the reference composition. Future studies should consider these possibilities.

Furthermore, statistical techniques underpinning Mekary et al. \[[@CR12]\] ISM, Chastin et al. \[[@CR13]\] ISM, and Dumuid et al. \[[@CR14]\] ISM are different; hence the findings of studies using different ISM models may not necessarily be directly comparable. Moreover, a recent study \[[@CR91]\] indicated there may be substantial differences in estimates obtained from ISMs proposed by Mekary et al. \[[@CR12]\] and Dumuid et al. \[[@CR14]\]. It is, therefore, important for future studies to clearly specify which ISM model was used. It is important to note, however, that none of the three ISMs can mitigate standard limitations of studies in this area, such as poor measurement of the exposure, potential reverse causality, and unmeasured or poorly measured potential confounding variables.

The main limitation of the current body of evidence pertains to the low number of studies that included all daily movement-related behaviours (e.g., sedentary behaviour, sleep, LPA, and MVPA) in the ISMs. While studies did adjust for many confounding variables, only those that included all of the behaviours received a point on the item regarding adjustments for confounding on the Newcastle-Ottawa scale, as otherwise the adjustments would be considered insufficient \[[@CR2]\]. Future studies should endeavour to include sedentary behaviour, sleep, LPA, and MVPA in their models. Most of the studies were cross-sectional, which is a major limitation of the current body of evidence on isotemporal substitution effects. While there were 18 prospective cohort studies included in this review, they cover only a limited range of outcomes. More longitudinal studies are needed to covering a wide range of health outcomes that are potentially associated with isotemporal substitutions.

Conclusions {#Sec34}
===========

There is a notable increase in interest in the associations between time reallocation among movement-related behaviours and their relationship to health outcomes. While much media coverage has focused on the adverse effects of prolonged sedentary behaviour \[[@CR93]\], evidence in this review suggests it would be more appropriate to shift the focus on the importance of reallocating time spent in sedentary behaviour to time spent in physical activity. The approach taken in this review broadens the physical activity behavioural arena, for both researchers and policymakers. While the current body of evidence indicates that time reallocation between sleep, sedentary behaviour, LPA, and MVPA may be associated with a number of health outcomes, there is a need for future studies employing longitudinal study designs, taking into account all movement behaviours, and examining a wider range of health, psychological, social, economic, and environmental outcomes. Future ISM studies on outcomes such as stroke, myocardial infarction, and cardiovascular disease death endpoints are warranted, given the current lack of evidence in this area.
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